From owner-ageing@net.bio.net Fri Sep 01 23:00:00 1995
Path: biosci!agate!howland.reston.ans.net!tank.news.pipex.net!pipex!dispatch.news.demon.net!demon!sunsite.doc.ic.ac.uk!lyra.csx.cam.ac.uk!news
From: Jong <jong@mrc-lmb.cam.ac.uk>
Newsgroups: bionet.molbio.ageing
Subject: (no subject)
Date: 2 Sep 1995 09:57:06 GMT
Organization: MRC
Lines: 14
Message-ID: <4299pi$fes@lyra.csx.cam.ac.uk>
NNTP-Posting-Host: sonja.acad.cai.cam.ac.uk
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.2b4 (Windows; I; 16bit)

Dear,

I have made a page on the abstracts of Ginseng related
scientific research. It is on;

http://sonja.acad.cai.cam.ac.uk/aging/ginseng/ginseng.htm

If you know any more interesting things on it, please
let me know.

cheers,

Jong


From owner-ageing@net.bio.net Sat Sep 02 23:00:00 1995
Path: biosci!bloom-beacon.mit.edu!gatech!news.uoregon.edu!news.u.washington.edu!root
From: Lance Stewart <L6138@u.washington.edu>
Newsgroups: bionet.molbio.ageing
Subject: (no subject)
Date: 3 Sep 1995 04:56:53 GMT
Organization: university of washington
Lines: 4
Message-ID: <42bcil$m30@nntp3.u.washington.edu>
NNTP-Posting-Host: cs103-16.u.washington.edu
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.1N (Macintosh; I; 68K)
X-URL: news:bionet.molbio.ageing

Does Geron corp. have a Homepage?  How can I invest in this exciting 
company?  Lance.



From owner-ageing@net.bio.net Sat Sep 02 23:00:00 1995
Path: biosci!agate!sunsite.doc.ic.ac.uk!dispatch.news.demon.net!demon!btnet!newsfeed.internetmci.com!news.uoregon.edu!vixen.cso.uiuc.edu!news.ecn.bgu.edu!psuvax1!news.eecs.nwu.edu!newsfeed.acns.nwu.edu!news.cc.uic.edu!E1.ED.UIC.EDU!u56375
From: u56375@uicvm.uic.edu (Dr. R. Krishnaraj)
Newsgroups: bionet.molbio.ageing
Subject: Post-Doc Position
Date: Thu, 31 Aug 1995 21:38:50
Organization: University of Illinois at Chicago
Lines: 10
Message-ID: <u56375.2.0015A65A@uicvm.uic.edu>
NNTP-Posting-Host: e1.ed.uic.edu
X-Newsreader: Trumpet for Windows [Version 1.0 Rev A]

POSTDOCTORAL RESEARCH ASSOCIATESHIP available immediately for a Ph.D or 
equivalent with experience in molecular immunology (flow cytometry, 
quantitative, PCR, cytokines, etc.) to study human NK cells (NIH funded). Send 
curriculum vitae, reprints and three reference letters to: Dr. R. Krishnaraj, 
University of Illinois at Chicago, Department of Medicine (M/C 787), 840 South 
Wood Street, Chicago, IL 60612. FAX 312-413-2693.
--
Educational Technology Lab
University of Illinois at Chicago
E-Mail: u29440@uicvm.uic.edu

From owner-ageing@net.bio.net Sat Sep 02 23:00:00 1995
Path: biosci!agate!newsxfer.itd.umich.edu!newsfeed.internetmci.com!news.uoregon.edu!vixen.cso.uiuc.edu!uwm.edu!psuvax1!news.eecs.nwu.edu!newsfeed.acns.nwu.edu!news.cc.uic.edu!E1.ED.UIC.EDU!u56375
From: u56375@uicvm.uic.edu (Dr. R. Krishnaraj)
Newsgroups: bionet.molbio.ageing
Subject: Post-Doc position or Research specialist
Date: Thu, 31 Aug 1995 21:51:51
Organization: University of Illinois at Chicago
Lines: 18
Message-ID: <u56375.4.0015DDEB@uicvm.uic.edu>
NNTP-Posting-Host: e1.ed.uic.edu
X-Newsreader: Trumpet for Windows [Version 1.0 Rev A]

POSTDOCTORAL RESEARCH ASSOCIATESHIP avaialable immediately 
with experience in molecular immunology (flow cytometry, quantitative PCR, 
cytokines, etc.) to study human NK cells (NIH funded). Send curriculum vitae, 
reprints and three reference letters to: Dr. R. Krishnaraj, University of Illinois 
at Chicago, Department of Medicine (M/C 787), 840 South Wood Street, 
Chicago, IL 60612. FAX 312-413-2693.

RESEARCH SPECIALIST: Part-time (or full-time, if funds are available) 
Research Specialist: BS or MS with some experience in immunology tissue 
culture and molecular biology techniques to work on human blood samples. 
Available immediately. Send resume to Dr. Krishnaraj, Geriatric Medicine 
(M/C 787) University of Illinois, 840 S. Wood St, Chicago, IL 60612. Fax 312-
413-2693.

--
Educational Technology Lab
University of Illinois at Chicago
E-Mail: u29440@uicvm.uic.edu

From owner-ageing@net.bio.net Sun Sep 03 23:00:00 1995
Path: biosci!bloom-beacon.mit.edu!usc!cs.utexas.edu!howland.reston.ans.net!news.sprintlink.net!news.crd.ge.com!rebecca!gk1702
From: gk1702@csc.albany.edu (KRISHNA GOPALA S)
Newsgroups: bionet.molbio.ageing
Subject: situation wanted
Date: 4 Sep 1995 03:03:20 GMT
Organization: The University at Albany
Lines: 214
Distribution: usa
Message-ID: <42dq9o$85a@rebecca.albany.edu>
NNTP-Posting-Host: eve.albany.edu

                                                 


 

                               RESUME


                                                       From
                                                       Mr.S.Gopal
                                                       248 Shakerrun Apts.
                                                       Albany, NY-12205.
                                                       Tel:(518)-456-1604
              

    sub: application for electron microscopist-
         cum-computer programmer.



    EDUCATION: 

    1992-1993          :  Certificate in electron microscopy technician
                            from V.A.Hospital, Albany, NY.

    1987-1990          :  M.S. in Biology from Meerut University, India.

    1985-1990          :  Certificate in computer programming  from M.K.
                          University, India.
                          Experience on basic, cobol, fortran, dbase-iii,
                          dbase-iv, wordperfect, lotus-123, turbo prolog,
                          pl/1, c, c++, visual basic, assembly language,
                          database management, systems analysis & design,
                          management information systems, business data
                          processing, pascal, turbo-pascal, excel,
                          image processing, operating systems like dos,
                          unix, vax etc.

     EXPERIENCE:

     1993-Continuing   : Electron microscopist-cum-computer programmer
                         at NYS Dept of health, Albany, NY.
                         Duties: writing scientific programs for 3-D image 
                         analysis by spider and web software.
                         Specimen preparation, processing for Trans-
                         mission, Scanning, Cryo-Electron Microscopes,
                         ultramicrotomy, positive , negative staining
                           techniqs, operation, maintainance of microscopes,
                         photography techniques, elemental analysis and
                         image analysis.

    
   
 

































































































































































From owner-ageing@net.bio.net Sun Sep 03 23:00:00 1995
Path: biosci!bloom-beacon.mit.edu!usc!cs.utexas.edu!howland.reston.ans.net!news.sprintlink.net!news.crd.ge.com!rebecca!gk1702
From: gk1702@csc.albany.edu (KRISHNA GOPALA S)
Newsgroups: bionet.molbio.ageing
Subject: situation wanted
Date: 4 Sep 1995 03:02:32 GMT
Organization: The University at Albany
Lines: 26
Distribution: usa
Message-ID: <42dq88$858@rebecca.albany.edu>
NNTP-Posting-Host: eve.albany.edu

Newsgroups: capdist.general
from: gopala s.krishna
subject: electron microscopist position-situation wanted
summary: resume
Followup-To:anywhere in usa
Distribution: usa
Organization: The University at Albany
Cc: 
Keywords: situation wanted

                           SITUATION  WANTED
     B.S, M.S, Master Of philosophy in Biology, certificate in
     Electron Microscopy from V.A.Hospital, Albany, NY.  Two
     years experience on Transmission, Scanning, Cryo-Electron
     microscopes, elemental analysis and image analysis.
     Available immediately. Willing to relocate. Call (518)-456-1604
     or write to:
                 Mr.S.Gopal
                 248 Shakerrun Apts.
                 Albany, NY-12205.
                 (518)-456-1604
 
                           




From owner-ageing@net.bio.net Sun Sep 03 23:00:00 1995
Path: biosci!TENET.EDU!dashley
From: dashley@TENET.EDU (Don Ashley)
Newsgroups: bionet.molbio.ageing
Subject: Investing In Geron
Date: 3 Sep 1995 20:09:09 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 12
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.OSF.3.91.950903220455.18929D-100000@Gayle-Gaston.tenet.edu>
References: <42bcil$m30@nntp3.u.washington.edu>
NNTP-Posting-Host: net.bio.net


Let me know when you find out.   I think Japan paid Geron $20 million 
recently for rights to market their cancer arresting procedures.

On 3 Sep 1995, Lance Stewart wrote:

> Does Geron corp. have a Homepage?  How can I invest in this exciting 
> company?  Lance.
> 
> 
> 
> 

From owner-ageing@net.bio.net Mon Sep 04 23:00:00 1995
Path: biosci!demo.ucl.ac.be!wunsch
From: wunsch@demo.ucl.ac.be (WUNSCH Guillaume)
Newsgroups: bionet.molbio.ageing
Subject: Seminars on Longevity Research
Date: 5 Sep 1995 05:12:57 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 67
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9509051208.AA20828@sci1.sri.ucl.ac.be>
NNTP-Posting-Host: net.bio.net

Dear Colleagues, 

   The purpose of this message is to inform you about the significant extension 
of the list of our scientific lectures and seminars on longevity research 
after our 3 recent presentations on the III European Congress of Gerontology in 
Amsterdam and a seminar at the University of Utrecht. 

   The new updated schedule of our seminars is printed below. We would be 
happy to give a seminar in your organization too (especially if you are 
located in Europe) and to discuss the opportunities for scientific 
collaboration on longevity research and centenarian studies. 

   Sincerely yours,

   Dr.Leonid A.Gavrilov, Ph.D.
   Dr.Natalia S.Gavrilova, Ph.D. 

P.S.: The updated extended list of our seminars is printed below.
******************************************************************


OUR SCHEDULE OF LECTURES AND SEMINARS ON LONGEVITY RESEARCH:

1. Belgium. September 5-13, 15-20.
   Contact person: Professor Guillaume Wunsch.
   Phone: (32 10) 47 29 51
   Fax: (32 10) 47 29 52
   Working Address: Dr.Leonid A.Gavrilov, Ph.D.
                    c/o Prof.G.Wunsch
                    Institut de demographie
                    place Montesquieu, 1/17
                    B-1348 Louvain-la-Neuve
                    Belgium

   Home Address: Dr.Leonid A.Gavrilov, Ph.D.
                 c/o Mrs.Cecile Goossens
                 Clos des Molons, 1
                 B-1348 Louvain-la-Neuve
                 Belgium
     Home phone: (32 10) 45 07 67

2. United Kingdom. September 13-14 and perhaps later.
   Contact person: Dr. Michael Murphy.
   Phone: 0171-405 7686
   Fax: 0171-955 6833
   Address: Dr.Leonid A.Gavrilov,Ph.D.
            c/o Dr.M.Murphy
            Population Studies
            London School of Economics
            Houghton Street
            London WC2A 2AE
            UK

3. France. September 21-22 and perhaps later.
   Contact person: Dr.Michel Allard.
   Phone: 33(1) 44 96 10 95
   Fax: 33(1) 44 96 11 99
   Address: Dr. Leonid A.Gavrilov,Ph.D.
            c/o Dr.Michel Allard
            IPSEN Foundation
            24, rue Erlanger
            75781 PARIS cedex 16
            France

P.S.: This list might be extended in future.
9


From owner-ageing@net.bio.net Tue Sep 05 23:00:00 1995
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!EU.net!news.sprintlink.net!in2.uu.net!comp.vuw.ac.nz!waikato!auckland.ac.nz!kcbbs!planet!chambers!steve
From: steve@chambers.ak.planet.co.nz (Steve Chambers)
Newsgroups: bionet.molbio.ageing,sci.life-extension
Subject: Re: solid data that says cancer caused by ageing process (Forwarded article)
Message-ID: <s9gTwAJBBh107h@chambers.ak.planet.co.nz>
Date: Wed, 6 Sep 95 17:15:24 +1200
References: <grovesa-0109950933580001@131.215.5.168>
Organization: PlaNet (Auckland New Zealand)
Lines: 33
Xref: biosci bionet.molbio.ageing:1940 sci.life-extension:7050

In <grovesa-0109950933580001@131.215.5.168> grovesa@starbase1.caltech.edu (Andrew K. Groves) writes:
>In article <UwyRwA3IBh107h@chambers.ak.planet.co.nz>,
>steve@chambers.ak.planet.co.nz (Steve Chambers) wrote:

>> Let's tidy this discussion up by reframing it.  I say that if you 
>> succeed in preventing aging you'll also have eliminated cancer.  I'm 
>> keen for anyone to present arguments to the contrary.  

>An interesting thought - although do you also mean to include childhood
>cancers such as neuroblastomas, or embryonal carcinomas? These are
>screw-ups right at the outset of life, and whether they are also due to a
>manifestation of the ageing process is a moot point.

Sure, why not?  Just because an aging process is most observable late
in life doesn't mean that it hasn't been going on throughout.  Adults may
not have neuroblasts and other early development cell types but that's
not important - it's the somatic mutations (which can happen at any age) 
that are the "aging" process of interest here. 

Besides, we're quite happy to conceptualize Werner's and other progerias 
as premature aging.  Why not other age-linked phenomenon that occur in
childhood?

Steve 

PS  Andy - We're talking about aging of whole organisms here ;-)
    Good to hear from you again.

-- 
 ________________________ 
(I_lurk,_therefore_I_am!_\  ,,,                           Steve Chambers
                           (o o)          steve@chambers.ak.planet.co.nz
-----------------------oOO--(_)--OOo------------------------------------

From owner-ageing@net.bio.net Tue Sep 05 23:00:00 1995
Path: biosci!demo.ucl.ac.be!wunsch
From: wunsch@demo.ucl.ac.be (WUNSCH Guillaume)
Newsgroups: bionet.molbio.ageing
Subject: Funds for Aging Research
Date: 6 Sep 1995 04:26:54 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 73
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9509061122.AA00536@sci1.sri.ucl.ac.be>
NNTP-Posting-Host: net.bio.net

        
Dear Colleagues,

   We have just received an information from European Community grant 
agency that a lot of funds could be received for our research work 
on aging and longevity on condition of international collaboration.

   We are looking for scientific partners in order to write joint 
grant application. Our schedule of the visits to the UK, France and 
Belgium is printed below (including fax numbers).

   The scientists interested in participation in our project based on our
previous research (described in our book "The Biology of Life Span", Harwood
Academic Publisher, 1991) are invited to join us.

   Sincerely yours,

   Dr.Leonid A.Gavrilov, Ph.D.
   Principal Research Scientist, Moscow State University

   Dr.Natalia S.Gavrilova, Ph.D.
   Senior Research Scientist
   Institute for System Analysis, Russian Academy of Sciences


P.S.: Our schedule is printed below for your information.
*************************************************************

OUR SCHEDULE OF LECTURES AND SEMINARS ON LONGEVITY RESEARCH:

1. Belgium. September 5-13, 15-20.
   Contact person: Professor Guillaume Wunsch.
   Phone: (32 10) 47 29 51
   Fax: (32 10) 47 29 52
   Working Address: Dr.Leonid A.Gavrilov, Ph.D.
                    c/o Prof.G.Wunsch
                    Institut de demographie
                    place Montesquieu, 1/17
                    B-1348 Louvain-la-Neuve
                    Belgium

   Home Address: Dr.Leonid A.Gavrilov, Ph.D.
                 c/o Mrs.Cecile Goossens
                 Clos des Molons, 1
                 B-1348 Louvain-la-Neuve
                 Belgium
     Home phone: (32 10) 45 07 67

2. United Kingdom. September 13-14 and perhaps later.
   Contact person: Dr. Michael Murphy.
   Phone: 0171-405 7686
   Fax: 0171-955 6833
   Address: Dr.Leonid A.Gavrilov,Ph.D.
            c/o Dr.M.Murphy
            Population Studies
            London School of Economics
            Houghton Street
            London WC2A 2AE
            UK

3. France. September 21-22 and perhaps later.
   Contact person: Dr.Michel Allard.
   Phone: 33(1) 44 96 10 95
   Fax: 33(1) 44 96 11 99
   Address: Dr. Leonid A.Gavrilov,Ph.D.
            c/o Dr.Michel Allard
            IPSEN Foundation
            24, rue Erlanger
            75781 PARIS cedex 16
            France

P.S.: This list might be extended in future.


From owner-ageing@net.bio.net Tue Sep 05 23:00:00 1995
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!news.larc.nasa.gov!lll-winken.llnl.gov!fnnews.fnal.gov!nntp-server.caltech.edu!NewsWatcher!user
From: grovesa@starbase1.caltech.edu (Andrew K. Groves)
Newsgroups: bionet.molbio.ageing,sci.life-extension
Subject: Re: solid data that says cancer caused by ageing process (Forwarded article)
Date: 6 Sep 1995 17:43:12 GMT
Organization: California Institute of Technology
Lines: 34
Message-ID: <grovesa-0609951039390001@131.215.5.168>
References: <grovesa-0109950933580001@131.215.5.168> <s9gTwAJBBh107h@chambers.ak.planet.co.nz>
NNTP-Posting-Host: mac168.bio.caltech.edu
Xref: biosci bionet.molbio.ageing:1942 sci.life-extension:7053

In article <s9gTwAJBBh107h@chambers.ak.planet.co.nz>,
steve@chambers.ak.planet.co.nz (Steve Chambers) wrote:


> Sure, why not?  Just because an aging process is most observable late
> in life doesn't mean that it hasn't been going on throughout.  Adults may
> not have neuroblasts and other early development cell types but that's
> not important - it's the somatic mutations (which can happen at any age) 
> that are the "aging" process of interest here. 
> 
> Besides, we're quite happy to conceptualize Werner's and other progerias 
> as premature aging.  Why not other age-linked phenomenon that occur in
> childhood?
> 

I can't really carry on the debate, as I don't know enough about the
molecular lesions that have been implicated in embryonic and childhood
cancers.I guess that if the mutation was caused by a mutation in the
*parent's* germ cells, then one could quite easily claim it to be
age-related!!!

> 
> PS  Andy - We're talking about aging of whole organisms here ;-)
>     Good to hear from you again.
> 

Organisms? What are they? Can you grow them in a dish?????

:)

-- 
Andy Groves
Division of Biology, 216-76
California Institute of Technology

From owner-ageing@net.bio.net Wed Sep 06 23:00:00 1995
Path: biosci!demo.ucl.ac.be!wunsch
From: wunsch@demo.ucl.ac.be (WUNSCH Guillaume)
Newsgroups: bionet.molbio.ageing
Subject: New book on Longevity Research
Date: 7 Sep 1995 06:18:58 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 75
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9509071308.AA12927@sci1.sri.ucl.ac.be>
NNTP-Posting-Host: net.bio.net


Dear Colleagues,

   After our recent 3 presentations at the III European Congress of
Gerontology in Amsterdam we have received an invitation from the Karger
Publisher (from Dr.Thomas J.Karger personally) to write a book about our
new results in addition to our previous book "The Biology of Life Span"
published in 1991 by Harwood Academic Publishers.

   We can easily write the whole new book ourselves but it seems to us very
interesting to try to create an international team of book coauthors since
it will promote greatly scientific discussions and debates and scientific
collaboration within such a team.

   We would like to invite at least one scientist from Europe, USA and
Japan to join us in our new book project and to write a book that will
be a result of scientific discussions between scientists of these
different cultures.

   Sincerely yours,

   Dr.Leonid A.Gavrilov, Ph.D.
   Member of the Council of Russian Gerontological Society
   Principal Research Scientist, Moscow State University

   Dr.Natalia S.Gavrilova, Ph.D.
   Senior Research Scientist
   Instutute of System Analysis, Russian Academy of Sciences

P.S.: Our detailed schedule is printed below for your information.
*********************************************************************

1. Belgium. September 5-13, 15-20.
   Contact person: Professor Guillaume Wunsch.
   Phone: (32 10) 47 29 51
   Fax: (32 10) 47 29 52
   Working Address: Dr.Leonid A.Gavrilov, Ph.D.
                    c/o Prof.G.Wunsch
                    Institut de demographie
                    place Montesquieu, 1/17
                    B-1348 Louvain-la-Neuve
                    Belgium

   Home Address: Dr.Leonid A.Gavrilov, Ph.D.
                 c/o Mrs.Cecile Goossens
                 Clos des Molons, 1
                 B-1348 Louvain-la-Neuve
                 Belgium
     Home phone: (32 10) 45 07 67

2. United Kingdom. September 13-14 and perhaps later.
   Contact person: Dr. Michael Murphy.
   Phone: 0171-405 7686
   Fax: 0171-955 6833
   Address: Dr.Leonid A.Gavrilov,Ph.D.
            c/o Dr.M.Murphy
            Population Studies
            London School of Economics
            Houghton Street
            London WC2A 2AE
            UK

3. France. September 21-22 and perhaps later.
   Contact person: Dr.Michel Allard.
   Phone: 33(1) 44 96 10 95
   Fax: 33(1) 44 96 11 99
   Address: Dr. Leonid A.Gavrilov,Ph.D.
            c/o Dr.Michel Allard
            IPSEN Foundation
            24, rue Erlanger
            75781 PARIS cedex 16
            France

P.S.: This list might be extended in future.


From owner-ageing@net.bio.net Thu Sep 07 23:00:00 1995
Newsgroups: bionet.molbio.ageing
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!news.sprintlink.net!in2.uu.net!nih-csl!postman
From: Robert hewitt <rhewitt@helix.nih.gov>
Subject: apoptosis and trypsinization
Content-Type: text/plain; charset=us-ascii
Message-ID: <1995Sep8.005448.14045@alw.nih.gov>
Sender: postman@alw.nih.gov (AMDS Postmaster)
Nntp-Posting-Host: 128.231.221.68
Content-Transfer-Encoding: 7bit
Organization: NCI, NIH
Mime-Version: 1.0
Date: Fri, 8 Sep 1995 00:54:48 GMT
X-Mailer: Mozilla 1.1N (Macintosh; I; PPC)
X-Url: news: bionet.molbio.ageing
Lines: 31


Dear Internetter,

I have been trying to estimate the level of apoptosis in the SW480 colon
cancer cell line by propidium iodide staining and flow cytometry.  The
result I get is that 30% of cells are apoptotic, which seems awfully 
high!

I wonder whether I may be inducing apotosis when preparing the single 
cell
suspension.  The procedure I use is to trypsinize, resuspend in DMEM + 
10%
FBS, spin at 700 rpm for 5 mins in a Sorvall benchtop, resuspend in PBS
without calcium or magnesium, count, then spin again, then resuspend in 
an
appropriate volume of PBS, before fixation.  All this is completed in
between 40 and 60 minutes.  The whole procedure is done at room
temperature to avoid "cold shock" induction of apoptosis.
                                                           
Is it likely that I could be inducing apoptosis by the above procedure?
If so, then would there be evidence of apotosis given the fact that 
cells
are fixed within 60 minutes of trypsinization?

Any comments would be gratefully received.

Thanks in advance,

Robert Hewitt.



From owner-ageing@net.bio.net Fri Sep 08 23:00:00 1995
Path: biosci!agate!newsxfer.itd.umich.edu!newsfeed.internetmci.com!EU.net!howland.reston.ans.net!news-e1a.megaweb.com!newstf01.news.aol.com!newsbf02.news.aol.com!not-for-mail
From: mikemldvn@aol.com (MikeMldvn)
Newsgroups: bionet.molbio.ageing
Subject: Talking to the hard of hearing
Date: 7 Sep 1995 03:23:53 -0400
Organization: America Online, Inc. (1-800-827-6364)
Lines: 37
Sender: root@newsbf02.news.aol.com
Message-ID: <42m6m9$gnd@newsbf02.news.aol.com>
Reply-To: mikemldvn@aol.com (MikeMldvn)

Talking to the hard of hearing 

About a year or so ago I posted in several places online a list of *tips
for talking to the hard of hearing*.  I plan to repeat the posting online
and to also e-mail the list to news services and other media as a *public
service* informational item.  Before I do so, I invite additional *tips*
from hearing experts, teachers, and other knowledgeable persons through
this general posting which is being placed in several AOL forums and
Internet newsgroups.  Please e-mail your input to   (AOL) mikemldvn   or 
(Internet) mikemldvn@aol.com      The *tips* that I have to date include
the following:            

1.  Face the hard of hearing person directly, and on the same level with
him/her, whenever possible.

2.  If you are eating, chewing, smoking, etc., while talking, your speech
will be more difficult to understand.

3.  Reduce background noises when carrying on conversations  --  turn off
the radio or TV.

4.  Keep your hands away from your face while talking.

5.  If a person has difficulty understanding something, find a different
way of saying the same thing, rather than repeating the original words
over and over.

6.  Recognize that hard of hearing people hear and undertand less well
when they are tired or ill.

7.  Never talk from another room.  Be sure to get the person's attention
before you start speaking to him/her.

8.  Speak in a normal fashion without shouting.  See that the light is not
shining in the eyes of the hard of hearing person.

Mike Moldeven

From owner-ageing@net.bio.net Sat Sep 09 23:00:00 1995
Path: biosci!agate!howland.reston.ans.net!news.sprintlink.net!in2.uu.net!news.compuserve.com!news.production.compuserve.com!news
From: Patrick R. Jones <102570.2734@CompuServe.COM>
Newsgroups: bionet.molbio.ageing,bionet.molbio.bio-matrix,bionet.molbio.embldatabank,bionet.molbio.evolution,bionet.molbio.gdb
Subject: Need Help
Date: 10 Sep 1995 20:08:40 GMT
Organization: Personal
Lines: 19
Message-ID: <42vgk8$og2$8@mhafn.production.compuserve.com>
Xref: biosci bionet.molbio.ageing:1947 bionet.molbio.bio-matrix:632 bionet.molbio.embldatabank:540 bionet.molbio.evolution:3432 bionet.molbio.gdb:360

I am a undergraduate student in biology.  Some day I hope to go to 
graduate school in biochemistry. My grades are good enough but I 
am afraid that this may not be enough to get in.  I am looking for 
something to set myself apart from the other students.  At this 
point I am at a loss on what to do.  I have no real resources to 
work on projects in the areas that interest me. Does anybody have 
any ideas?  I do have one useful skill.  I am a professional 
computer programmer. I don’t mean someone who has taken a FORTRAN 
class and is working as a work-study student, but a 10 year 
application programming veteran in the computing industry.  If I 
could use this skill great if not, I don’t care.  I need something 
to further my career; something good.  Please help!!!  I know that 
somebody out there knows of something I could do.

	Thank you for your time!!!
	Patrick R. Jones

-- 
<<Evolution isn’t just a good idea. Its the law!>>

From owner-ageing@net.bio.net Sun Sep 10 23:00:00 1995
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!EU.net!newsfeed.internetmci.com!news.compuserve.com!news.production.compuserve.com!news
From: ray and lisa <71623.3126@CompuServe.COM>
Newsgroups: bionet.molbio.ageing
Subject: NEW ANTI-AGING DRUG!!!
Date: 11 Sep 1995 00:18:17 GMT
Organization: n/a
Lines: 3
Message-ID: <42vv89$t7s$1@mhade.production.compuserve.com>

heard about new anti-aging drug out in Austria. would like to 
find out more about it & how to obtain it. info about other 
proven drugs would be helpful too.

From owner-ageing@net.bio.net Mon Sep 11 23:00:00 1995
Newsgroups: bionet.molbio.ageing,bionet.molbio.bio-matrix,bionet.molbio.embldatabank,bionet.molbio.evolution,bionet.molbio.gdb
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!news.cac.psu.edu!news.math.psu.edu!psuvax1!gvls1!newsfeed.pitt.edu!godot.cc.duq.edu!news.duke.edu!news-server.ncren.net!hearst.acc.Virginia.EDU!murdoch!darwin.clas.Virginia.EDU!mgk
From: mgk@darwin.clas.Virginia.EDU (Mahlon G. Kelly)
Subject: Re: Need Help
X-Nntp-Posting-Host: darwin.clas.virginia.edu
Message-ID: <DEs4FF.I5y@murdoch.acc.Virginia.EDU>
Sender: usenet@murdoch.acc.Virginia.EDU
Organization: uva
References: <42vgk8$og2$8@mhafn.production.compuserve.com>
Date: Tue, 12 Sep 1995 06:23:38 GMT
Lines: 33
Xref: biosci bionet.molbio.ageing:1949 bionet.molbio.bio-matrix:633 bionet.molbio.embldatabank:541 bionet.molbio.evolution:3445 bionet.molbio.gdb:361

Patrick R. Jones  writes:
> I am a undergraduate student in biology.  Some day I hope to go to 
> graduate school in biochemistry. My grades are good enough but I 
> am afraid that this may not be enough to get in.  I am looking for 
> something to set myself apart from the other students.  At this 
> point I am at a loss on what to do.  I have no real resources to 
> work on projects in the areas that interest me. Does anybody have 
> any ideas?  I do have one useful skill.  I am a professional 
> computer programmer. I don’t mean someone who has taken a FORTRAN 
> class and is working as a work-study student, but a 10 year 
> application programming veteran in the computing industry.  If I 
> could use this skill great if not, I don’t care.  I need something 
> to further my career; something good.  Please help!!!  I know that 
> somebody out there knows of something I could do.
> 
> 	Thank you for your time!!!
> 	Patrick R. Jones
> 
> -- 
> <<Evolution isn’t just a good idea. Its the law!>>

Certainly there must be some investigator, either in your
university or at a nearby medical center, who would be only too
happy to use your skills in a for-credit research project. That
would certainly look good on your application. Another hint:
try to get to know your faculty members well enough that when
it comes time to get letters of recommendation they can write
something fairly personal, not just a form letter that says
they had you in a class.
-- 
Associate Professor (Emeritus)
University of Virginia
mgk@darwin.clas.virginia.edu

From owner-ageing@net.bio.net Wed Sep 13 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!news.sprintlink.net!news.uoregon.edu!vixen.cso.uiuc.edu!uchinews!apollo.it.luc.edu!usenet
From: nonn et al <nonn.robert@hines.va.gov>
Newsgroups: bionet.molbio.ageing,bionet.molbio.bio-matrix,bionet.molbio.embldatabank,bionet.molbio.evolution,bionet.molbio.gdb
Subject: Re: Need Help
Date: 14 Sep 1995 02:21:56 GMT
Organization: Loyola univ Chicago
Lines: 2
Message-ID: <4383k4$dcj@apollo.it.luc.edu>
References: <42vgk8$og2$8@mhafn.production.compuserve.com>
NNTP-Posting-Host: 147.126.163.163
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.2b2 (Windows; I; 16bit)
To: 102570.2734@CompuServe.COM
Xref: biosci bionet.molbio.ageing:1950 bionet.molbio.bio-matrix:634 bionet.molbio.embldatabank:542 bionet.molbio.evolution:3461 bionet.molbio.gdb:363

Grades are not enough, publish like a fiend and suck up to the big guns!


From owner-ageing@net.bio.net Thu Sep 14 23:00:00 1995
Path: biosci!OZEMAIL.COM.AU!pjhynes
From: pjhynes@OZEMAIL.COM.AU (Peter Hynes)
Newsgroups: bionet.molbio.ageing
Subject: Subscribe
Date: 15 Sep 1995 16:11:00 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 2
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199509152308.JAA14090@oznet02.ozemail.com.au>
NNTP-Posting-Host: net.bio.net

This is a test .. to forget it would be best.


From owner-ageing@net.bio.net Fri Sep 15 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!news.sprintlink.net!in1.uu.net!news1.digital.com!ames!lll-winken.llnl.gov!fnnews.fnal.gov!nntp-server.caltech.edu!NewsWatcher!user
From: cherbert@cco.caltech.edu (Curtis Herbert)
Newsgroups: bionet.molbio.ageing,bionet.molbio.bio-matrix,bionet.molbio.embldatabank,bionet.molbio.evolution,bionet.molbio.gdb
Subject: Re: Need Help
Date: Fri, 15 Sep 1995 18:48:47 +0900
Organization: Caltech
Lines: 24
Message-ID: <cherbert-1509951848470001@131.215.249.3>
References: <42vgk8$og2$8@mhafn.production.compuserve.com>
NNTP-Posting-Host: 131.215.249.3
Xref: biosci bionet.molbio.ageing:1952 bionet.molbio.bio-matrix:635 bionet.molbio.embldatabank:543 bionet.molbio.evolution:3480 bionet.molbio.gdb:365

In article <42vgk8$og2$8@mhafn.production.compuserve.com>, Patrick R.
Jones <102570.2734@CompuServe.COM> wrote:

> I am a undergraduate student in biology.  Some day I hope to go to 
> graduate school in biochemistry. My grades are good enough but I 
> am afraid that this may not be enough to get in.  I am looking for 
> something to set myself apart from the other students.  

snip

> 
> -- 
> <<Evolution isn’t just a good idea. Its the law!>>
Who's law?

I also urge you to try to do some undergraduate research. Make up a little
resume and hand-deliver it to some likely faculty members.  Ask them who
might be interested in you.   Also try to keep an eye open for ways to
apply your background; you have a valuable skill.  You might mention it to
some of the faculty types.  

Also, a better posting for this sort of thing might be: alt.grad-student.tenured

Curtis H.

From owner-ageing@net.bio.net Sat Sep 16 23:00:00 1995
Newsgroups: bionet.molbio.ageing,bionet.molbio.bio-matrix,bionet.molbio.embldatabank,bionet.molbio.evolution,bionet.molbio.gdb
Path: biosci!agate!howland.reston.ans.net!torn!utnut!utzoo!mes
From: mes@zoo.toronto.edu (Mark Siddall)
Subject: Re: Need Help
Message-ID: <DF1BMM.B3u@zoo.toronto.edu>
Date: Sun, 17 Sep 1995 05:37:33 GMT
References: <42vgk8$og2$8@mhafn.production.compuserve.com> <4383k4$dcj@apollo.it.luc.edu>
Organization: U of Toronto Zoology
Lines: 17
Xref: biosci bionet.molbio.ageing:1953 bionet.molbio.bio-matrix:636 bionet.molbio.embldatabank:544 bionet.molbio.evolution:3490 bionet.molbio.gdb:366

In article <4383k4$dcj@apollo.it.luc.edu> nonn et al <nonn.robert@hines.va.gov> writes:
>Grades are not enough, publish like a fiend and suck up to the big guns!
>


Good point, though I would add that any sucking up (or even lack thereof)
is going to make people think "Hmmm. what camp are they in...?"  and 
you will inevitably be taken on those grounds rather than for what you 
might have to say.  It's a shame, but as a young phylogeneticist, I 
assure you it's true.  If there's one thing that the majority does 
NOT respect out there... it's a firm conviction.  So don't have one...
you'll go further.
-- 
Mark E. Siddall                "I don't mind a parasite...
mes@vims.edu                    I object to a cut-rate one" 
Virginia Inst. Marine Sci.                     - Rick
Gloucester Point, VA, 23062

From owner-ageing@net.bio.net Sat Sep 16 23:00:00 1995
Path: biosci!agate!library.ucla.edu!info.ucla.edu!newsfeed.internetmci.com!news.sprintlink.net!parsifal.nando.net!usenet
From: newfound@vistech.com
Newsgroups: bionet.agroforestry,bionet.biology.tropical,bionet.jobs,bionet.jobs.wanted,bionet.molbio.ageing,bionet.molbio.evolution
Subject: Simply Success-->Eat SBG Algae-->Gain Health, Energy, Time, and Financial Freedom...
Date: Mon, 18 Sep 1995 01:47:03 GMT
Organization: News & Observer Public Access
Lines: 117
Message-ID: <43i8l5$b23@parsifal.nando.net>
NNTP-Posting-Host: grail1109.nando.net
X-Newsreader: Forte Free Agent 1.0.82
Xref: biosci bionet.agroforestry:2005 bionet.biology.tropical:1249 bionet.jobs.wanted:2597 bionet.molbio.ageing:1954 bionet.molbio.evolution:3493

You just took the first step to a better life.

First of all, this is a legitimate Multi-Level Marketing (MLM)
business that has been around for 13 years with more than 200,000
distributors.  (Note: Less than 5% of MLM’s survive their second
year).

We at Newfound Energy can show you how to gain:
	Health/weight loss
	Physical energy
	Mental clarity and alertness
	
	A network of distributors that --we build for you!!--
	Financial freedom ($500- $1500/ month in 6-12 months)
	Satisfaction of charity contribution (see 10% solution below)

The above list of benefits will change your life -- It sure changed
mine.

Check out our home page, this business will stand the scrutiny of
investigation.

Newfound Energy with Cell Tech
http://www.vistech.net/users/newfound

We are independent distributors of Super Blue Green Algae (c) (SBGA)
produced by Cell Tech (c).  SBGA is the most pure form of Algae on the
market.  Cell Tech (c) offers a complete line of products (based on
SBGA).  It is harvested from a lake in the pristine Cascade Mountains
in Oregon.  All nutrients are quickly locked into the tablets and
capsules by a patented process.  As a result, our bodies can easily
absorb this source of protein, enzymes, and vitamins.

As a distributor, you can consume this algae at wholesale  prices (30
% off) and enjoy the benefit of this super-food.  Many distributors do
not resell the product, they simply consume the product and tell their
friends and family about the results.  As they see the improvement in
your health, energy, and financial freedom they will be curious and
check it out for themselves.  Therefore, a network can be built with
little to no time or effort.  Additionally, we can build your downline
for you.

We build downlines.  Through a unique program offered by our upline,
you can simply consume the product ($50/month) and watch your business
grow automatically.  That’s right, the plan (The Guarantee Plan) has
been in effect for more than 1 year and has produced many wealthy
people.  References and copies of checks are available upon request
(see source of more info. below).  By the way, using this
program(letting us build your network for you), you can expect to
break even ($50/month) in 2-4 months; from then on, you get the algae
for free (no money out of your pocket).  

Due to an excellent network plan, distributors receive the following
benefits over other MLM’s:
	1.  Commission checks come directly to distributor from Cell Tech 
		- no writing of checks for your downline
		- no tracking of points/money of your downline!!!!!
	2.  Orders are sent from Cell Tech (c) directly to the distributor
		- receive in two days (other MLM’s can take up to 14 days)
		- no more weekly meetings at your house
		- no need to collect an inventory for your downline
	3.  Low cost of marketing supplies
		- tapes cost from 65 cents to a $1/ea 
		  (other MLM’s tapes could cost up to $5/ea)
		- videos cost from $1.50-$6
		  (other MLM’s videos could cost $5-$25/ea)
		- cheap brochures and visual aids
	4.  Low cost of product, low overhead for you.
		- only $50/6 months of purchases are required to stay active 
		- $50/ month requirement  to receive commission check
		   (other MLM’s monthly requirement could exceed $150)
	5.  Clean reputation
		- unlike some other MLM’s you will feel proud to tell
		   people you distribute a line of Health and Nutrition
   		   products (based on algae) and produced by Cell Tech (c).
	6.  Requirements of higher levels of commission bonus must 
	     only be met once
		- once you get promoted, you rate that level’s bonus 
		  percentage -- forever.
	7.  Unique product
	       	There is only one Super Blue Green Algae because no other  	
		environment on earth duplicates the wild and fertile ecology of 
		Klamath Lake.  By comparison, commercial freshwater Spirulina and 
		Chlorella must be grown in man-made ponds, under artificially 
		controlled conditions.  In 	these ponds the algae receives a
smaller 
		quantity of minerals and, more important, a far narrower range of
		nonorganic minerals.	

	8.  Health, energy and time to do more of what you want!


Consider all of these factors when comparing this MLM with others.

Finally, you will have the sense of satisfaction that comes with
contributing to charity.  Cell Tech (c) committed in 1992 to help feed
the masses and introduced the 10% Solution program.  From then on, 10%
of the yearly harvest will go “to people who have the greatest need
and the fewest resources.”  The following projects are now underway: 
	Nicaragua
	Cambodia
	Chernobyl
	Los Angeles (Cultivating Self-Worth in an Urban War Zone)
	American Indian Family Healing Center 
---------------------------------------------------------------------------------------
For more information, please contact me: Allen A. Harper
email: newfound@vistech.net

At least check out our home page, this business will stand the
scrutiny of investigation.  Don’t waste time.

http://www.vistech.net/users/newfound

or call Newfound Energy at 1-800-519-0013

PS: “wise men and women simply investigate what fools pass by...”


From owner-ageing@net.bio.net Tue Sep 19 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!news.sprintlink.net!parsifal.nando.net!usenet
From: newfound@vistech.net
Newsgroups: bionet.agroforestry,bionet.biology.tropical,bionet.jobs,bionet.jobs.wanted,bionet.molbio.ageing,bionet.molbio.evolution
Subject: Correction--> New Found Energy's email address is newfound@vistech.net (not newfound@vistech.com)
Date: Wed, 20 Sep 1995 14:37:42 GMT
Organization: News & Observer Public Access
Lines: 9
Message-ID: <43ouie$ct1@parsifal.nando.net>
NNTP-Posting-Host: grail1210.nando.net
X-Newsreader: Forte Free Agent 1.0.82
Xref: biosci bionet.agroforestry:2010 bionet.biology.tropical:1254 bionet.jobs.wanted:2636 bionet.molbio.ageing:1955 bionet.molbio.evolution:3508

Sorry,
On several previous postings our email address was incorrect.  We have
no connection with vistech.com. 

See our home page for details of our products:
http://www.vistech.net/users/newfound
                                  ^
                                  |


From owner-ageing@net.bio.net Tue Sep 19 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!news.sprintlink.net!news.crd.ge.com!rebecca!gk1702
From: gk1702@csc.albany.edu (KRISHNA GOPALA S)
Newsgroups: bionet.molbio.ageing
Subject: Electron Microscopy Study!
Date: 20 Sep 1995 18:09:56 GMT
Organization: The University at Albany
Lines: 21
Distribution: na
Message-ID: <43pldk$ovm@rebecca.albany.edu>
NNTP-Posting-Host: lilith.albany.edu


            ********************************************************
              Do  You  Have  Work  On  Transmission, Scanning, Cr-
            Electron Microscopes, Elemental Analysis and Image
            Analysis?
            *********************************************************
        
            I am a Certified Electron Microscopist from V.A.Hospital,
            Albany, NY and I have two years experience on specimen    
            preparation, processing for Transmission, Scanning, Cryo-
            Electron Microscopes, Ultramicrotomy, Photographic techniques.
            If you send your specimen samples, I can process them and
            take very nice pictures under Transmission, Scanning Electron
            Microscopes and also perform elemental analysis under SEM
            and mail them to you.
            I charge very less money per sample comparative to other
            people.  I charge $10 per specimen.
            I can process any plant, animal specimens for Electron
            Microscpy study.  Please send $10 cash or check and specimen
            sample to Mr.Krishna, 248 Shakerrun Apts, Albany, NY-12205.
            *************************************************************

From owner-ageing@net.bio.net Wed Sep 20 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!uunet!in1.uu.net!newstf01.news.aol.com!newsbf02.news.aol.com!not-for-mail
From: spilchard@aol.com (S pilchard)
Newsgroups: bionet.molbio.ageing
Subject: Questions About Baldness
Date: 20 Sep 1995 21:44:32 -0400
Organization: America Online, Inc. (1-800-827-6364)
Lines: 7
Sender: root@newsbf02.news.aol.com
Message-ID: <43qg20$sk7@newsbf02.news.aol.com>
Reply-To: spilchard@aol.com (S pilchard)
NNTP-Posting-Host: newsbf02.mail.aol.com

I'm looking for reliable information concerning baldness, thinning hair,
and male pattern-baldness (I don't know any of the distinctions) and their
purported causes.  I'm also interested in any information about
preventing, arresting, or reversing receding hairlines, etc.  Perhaps, you
have some information or you can refer me to some sources.

Thanks

From owner-ageing@net.bio.net Wed Sep 20 23:00:00 1995
Path: biosci!LEX.LCCC.EDU!rcb1
From: rcb1@LEX.LCCC.EDU (Ron Blue)
Newsgroups: bionet.molbio.ageing
Subject: neuromodel
Date: 21 Sep 1995 06:11:22 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 69
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.3.89.9509210957.S26756-0100000@lex.lccc.edu>
References: <43qg20$sk7@newsbf02.news.aol.com>
NNTP-Posting-Host: net.bio.net


   The following is available by FTP:
   Note: this is Unix system which is case sensitive.
 
   ftp.tmn.com
   login: anonymous
   password: (your email address)
   cd Chaos-Complexity
   ls
   get BlueBlue-OpponentProcessing.txt
   bye

Abstract:

The correlational opponent-processing theory is a neuro homeostasis
integration psychological immune theory that would connect phenomena
such as sensation, perception, movement, habituation, memory,
representations, learning, cognition, personality, psychopathology,
paradoxical integration, emotion, and evolution of the mind under a
unified theory.

Perception/learning/cognition may be viewed as an effort to assimilate
and accommodate all experience into neuro-energy-efficient
eigenfunction equivalence or quasi-holographic correlational opponent-
processing recordings.

Stimuli causes brain wave modulations which interact with carrier or
reference wavelets.  This interaction creates a quasi-holographic
stimulus wavelet.  The opponent-process creates an opposing quasi-
holographic memory wavelet.  Through this process the correlations or
associations of experience are encoded to memory.  Every wavelet,
regardless of source or type, triggers an opposing wavelet.  The
function of the opposing wavelet or feedback is to diminish the
intensity of neural processing.  A wavelet potential is stored or hard
wired as long-term potentiation opponent-processes in nerve cells and
the interconnections between nerve cells.  The wavelets are quasi-
holographic and allow recovery of information due to the interaction of
reference carrier wavelets and stimuli, thought, motor movement, and
emotional arousal.

Outline:
       Discussion
       Neuro Net
       Quasi-holographic wavelets
       Habituation/immunization
       Memory
       Representations, copies or models
       Learning/Cognition
       Personality
       Sensations and Perceptions
       Movement
       Emotion
       Evolution
       Tools
       Implications
       Conclusion and applications from COP theory
            Discorrelation
            Education
            Biophysical
            Intelligence
            Defense Mechanisms
            Brain damage
            Creativity
            Brain Tape
            Computer Model
            Conclusion
       Bibliography
       Acknowledgments


From owner-ageing@net.bio.net Wed Sep 20 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!news.sprintlink.net!news.crd.ge.com!rebecca!gk1702
From: gk1702@csc.albany.edu (KRISHNA GOPALA S)
Newsgroups: bionet.molbio.ageing
Subject: Electron Microscopy Study!
Date: 21 Sep 1995 16:10:05 GMT
Organization: The University at Albany
Lines: 66
Distribution: na
Message-ID: <43s2ot$fu@rebecca.albany.edu>
NNTP-Posting-Host: eve.albany.edu


            ********************************************************
              Do  You  Have  Work  On  Transmission, Scanning, Cr-
            Electron Microscopes, Elemental Analysis and Image
            Analysis?
            *********************************************************
        
            I am a Certified Electron Microscopist from V.A.Hospital,
            Albany, NY and I have two years experience on specimen    
            preparation, processing for Transmission, Scanning, Cryo-
            Electron Microscopes, Ultramicrotomy, Photographic techniques.
            If you send your specimen samples, I can process them and
            take very nice pictures under Transmission, Scanning Electron
            Microscopes and also perform elemental analysis under SEM
            and mail them to you.
            I charge very less money per sample comparative to other
            people.  I charge $50 per sample.
            I can process any plant, animal specimens for Electron
            Microscpy study.  Please send $50 cash or check and specimen
            sample to Mr.Krishna, 248 Shakerrun Apts, Albany, NY-12205.
 
             Please E-mail your questions to:
                  
                gk1702@ix.netcom.com
            
            Approximate time for specimen preparation, processing 
            for TEM and SEM:

            Specimen processing time for TEM      24 Hours
            & SEM:                                     
            Ultramicrotomy, thick, thin
            section slides preparation,
            positive, negative staining
            techniques, observation under
            Transmission electron microscope
            depending upon microscope time      
            and photography techniques            1 to 2 days

            Specimen preparation for SEM
            i.e. sputter coating or sputtering
            or carbon coating, observing under
            SEM and taking pictures               1 to 2 days
   
            I need to pay for chemicals, electron microscopy time,
            for purchasing film for both TEM and SEM etc that is
            why I am charging $50 per specimen.  I apologize I
            mentioned $10 per sample in my last posting and it
            is not feasible for me.

            P.S.: This is not scam or some thing nonsense. 
                  I completed B.S. in Biology and Chemistry,
                  M.S. in Biology, Master of Philosophy in Biology,
                  one year intensive training on Electron Microscopy
                  at The School Of Electron Microscopy, Veterans
                  Hospital, Albany, NY and I am a certified
                  computerprogrammer.  I have strong ambition to
                  utilise my Electron Microscopy skills in the
                  field of Biology and Medicine.  This way, I
                  can fulfil my ambition to become a diagnostic
                  Electron Microscopist and inturn I will be 
                  useful to The School Of Electron Microscopy,
                  V.A.Hospital, Albany, NY.
            

           *************************************************************
                    

From owner-ageing@net.bio.net Wed Sep 20 23:00:00 1995
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!tank.news.pipex.net!pipex!news.sprintlink.net!in2.uu.net!EU.net!sun4nl!news.euro.net!usenet
From: Luc Sala <sala@euronet.nl>
Newsgroups: bionet.molbio.ageing
Subject: WANTED addresses of popular health magazines
Date: 21 Sep 1995 20:21:38 GMT
Organization: Sala Communications
Lines: 15
Message-ID: <43shgi$n42@news.euro.net>
NNTP-Posting-Host: p418.asp.euronet.nl
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.2b6 (Windows; I; 16bit)

Hi,

I would like to receive addresses plus phonenumbers of magazines
that publish articles concerning health and/or life extension, and which
are aimed at the general public.

Please don't reply to this email, but send mail to:

                 ferry@info.uba.uva.nl

Many thanks in advance,


Ferry


From owner-ageing@net.bio.net Thu Sep 21 23:00:00 1995
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!EU.net!howland.reston.ans.net!news.sprintlink.net!in2.uu.net!newstf01.news.aol.com!newsbf02.news.aol.com!not-for-mail
From: aprilworks@aol.com (AprilWorks)
Newsgroups: bionet.molbio.ageing
Subject: Retirement Living
Date: 22 Sep 1995 10:22:34 -0400
Organization: America Online, Inc. (1-800-827-6364)
Lines: 11
Sender: root@newsbf02.news.aol.com
Message-ID: <43ugra$4ft@newsbf02.news.aol.com>
Reply-To: aprilworks@aol.com (AprilWorks)
NNTP-Posting-Host: newsbf02.mail.aol.com

Can anyone help me locate guides to continuing care retirement
communities.  I am looking for any information that would help me find an
appropriate environment for my mother and her husband, who are in their
80's.  This may not be the appropriate newsgroup for answering this
question, so would also appreciate any guidance in finding the newsgroup
which would be most helpful to me.  I've looked and looked on the internet
and can't seem to find anything which addresses my questions.

TIA
April
AprilWorks@aol.com

From owner-ageing@net.bio.net Thu Sep 21 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!news.nic.surfnet.nl!highway.LeidenUniv.nl!usenet
From: Angelo Schouten <d_quale@dds.nl>
Newsgroups: bionet.molbio.ageing
Subject: This bionet newsgroup is alienated from its origin
Date: 21 Sep 1995 13:48:52 GMT
Organization: Leiden University, The Netherlands
Lines: 15
Message-ID: <43rqg4$hsd@highway.LeidenUniv.nl>
NNTP-Posting-Host: rulc12.leidenuniv.nl
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.2N (Windows; I; 16bit)

I always considered this bionet newsgroup to be a meeting place 
for experts on ageing. Why do I see so many commercial ads and 
"nag nags". Is this the inherent policy or simply a plain 
weakness?

No wonder that those seriously devoted to ageing seek comfort 
elsewhere. If gangrene starts to spread, it is better to amputate 
as quickly as possible. Not very funny unfortunately.

Yours truly,

Angelo Schouten (Physicist/Chemist)




From owner-ageing@net.bio.net Thu Sep 21 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!news.sprintlink.net!simtel!harbinger.cc.monash.edu.au!sol.ccs.deakin.edu.au!pc-rbp161.sci.deakin.edu.au!drierac
From: drierac@deakin.edu.au (Chris Driver)
Newsgroups: bionet.molbio.ageing
Subject: DHEA
Date: Fri, 22 Sep 1995 18:34:25
Organization: Deakin University
Lines: 12
Message-ID: <drierac.67.00129315@deakin.edu.au>
NNTP-Posting-Host: pc-rbp161.sci.deakin.edu.au
X-Newsreader: Trumpet for Windows [Version 1.0 Rev A]

To all readers and lurkers..

Will somemake some sort of comments about DHEA. Esepcially if it works and why 
it does (if it does)

Chris Dirver
Chris Driver, Ph D
School of Biology and Chemistry, Rusden Campus
Deakin University
662 Blackburn Rd
Clayton, VIC, 3168
AUSTRALIA

From owner-ageing@net.bio.net Thu Sep 21 23:00:00 1995
Path: biosci!biosci!not-for-mail
From: Jorge Braz <qjpcbraz@cc.fc.ul.pt>
Newsgroups: bionet.molbio.ageing
Subject: Oxidative stress as a cause for ageing
Date: 21 Sep 1995 22:19:15 -0700
Organization: Faculdade de Ciencias da Universidade de Lisboa
Lines: 4
Sender: biohelp@net.bio.net
Distribution: world
Message-ID: <Pine.SCO.3.91.950921134107.29268A-100000-100000-100000-100000@skull.cc.fc.ul.pt>
NNTP-Posting-Host: net.bio.net

	I am looking for any information about the reactions of oxygen 
radicals (o2.-, HO., O1, H2O2) with the DNA bases especially the rate 
constants and the products percentages of this reactions.
			 Jorge Braz

From owner-ageing@net.bio.net Thu Sep 21 23:00:00 1995
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!EU.net!news.sprintlink.net!news.onramp.net!news.tcst.com!dildog.lgc.com!news.sesqui.net!uuneo.neosoft.com!sam-slip-i2.NeoSoft.COM!pproctor
From: pproctor@sam.neosoft.com (Peter H. Proctor)
Newsgroups: bionet.molbio.ageing
Subject: Re: Questions About Baldness-- FAQ
Date: Thu, 21 Sep 1995 11:03:20 UNDEFINED
Organization: NeoSoft Internet Services   +1 713 968 5800
Lines: 235
Message-ID: <pproctor.478.00F8A0D9@sam.neosoft.com>
References: <43qg20$sk7@newsbf02.news.aol.com>
NNTP-Posting-Host: sam-slip-i2.neosoft.com
Keywords: Alopecia, balding, hairloss
X-Newsreader: Trumpet for Windows [Version 1.0 Rev B final beta #1]

In article <43qg20$sk7@newsbf02.news.aol.com> spilchard@aol.com (S pilchard) writes:
>From: spilchard@aol.com (S pilchard)
>Subject: Questions About Baldness
>Date: 20 Sep 1995 21:44:32 -0400

>I'm looking for reliable information concerning baldness, thinning hair,
>and male pattern-baldness (I don't know any of the distinctions) and their
>purported causes.  I'm also interested in any information about
>preventing, arresting, or reversing receding hairlines, etc.  Perhaps, you
>have some information or you can refer me to some sources.

FAQ: Hair-loss and Balding

Part 1: Pathophysiology and some treatment agents

Pattern Balding:

Incidence in males roughly corresponds to age (i.e.,at age
35, about 35% of males have it ). Incidence in women half to
third this, at least before menopause.

*Inheritance complicated.  Possibly: "autosomal dominant with
mixed penetrance". Translation: you can inherit from mom or
dad and it expresses itself variably.

*What you inherit is susceptibility to male sex hormones.
multiple factors, including increased uptake, conversion to
more active forms, receptor sites may be involved.

*Four major androgens: Testosterone, DHT, DHEA, and
androstenedione.  DHT most potent-- but, DHEA from adrenals
important in women and possibly men. Likewise, androstene
dione in men.

Other factors in balding: immunological, damage to blood
vessel lining.

_Emerging Model for Pattern Balding_ (after Kligman, others )

     Hormones do something to hair follicle which causes it
to be read as "foreign body" by immune system, which then
mounts an attack. Main damage in balding is probably
immunologically-mediated.  Damage to lining of blood vessels,
which produces hair growth-stimulatory factors, makes this
worse.

A) Evidence for hormonal factors:

     Castration, lack of DHT-receptors/enzymes (testicular
feminization) , feminine status block progression. However,
women and castrated males have other sources of androgens and
can still experience pattern loss.  Even complete castration
( as in male to female sex change operations ) does not reverse
balding much.

Immunological factors

* Microscopically, Balding looks like organ rejection.
Cells of your immune system clustor around the follicle base.
BTW,  Immune system cells normally cluster around the
hair follicle.   They may have a role in the normal hair cyle.

* Organ rejection drugs ( e.g., cyclosporin ) reverse
balding a whole lot better than antiandrogens.  This gives a
rough indication of the relative importance of hormonal
verses immunological factors in maintaining the balding state.

* Antibodies to hair follicles present in blood.

B) Blood Vessel Lining evidence

*Minoxidil, other agents may imitate hair growth factors (
nitric oxide radical, etc. ) produced by vessel lining.
In diseases involving damage to vessel lining
(e.g.,atherosclerosis) production of these is decreased.
Such diseases are associated epidemiologically with severe
balding.  Also, decreases in circulation reported in balding
scalp may reflect local damage to vessel lining

II) Treatment of Pattern Loss

Aside: Forget looking in the medical literature for new
agents.  Because of the commercial potential, everyone
(including me) goes after patents.  Most drug companies want
to keep things secret as long as possible and so often don't
publish on a new drug until it's just about ready for
commercial release.

    BTW,  when developing any drug, the first place a PhD
pharmacologist ( the guys who really develop drugs ) looks is
in the patent literature.   Most physicians and nonpharmacologist
biomedical researchers do not know about about looking at
patents,  so you will rarely see them quoted.

    Even if a researcher is just interested in basic mechanisms,
this is a bad mistake.  For example,  several patents from multiple
sources indicate that superoxide dismutases stimulate hair growth.
Further, another patent from the Procter and Gamble Company
involves using an inhibitor of SODases ( DDTC ) to inhibit
hair growth.

    The implication is that superoxide radical ( an important
messenger in many other systems) is also a messenger
modulating hair growth.   There is not a hint of this in
the  "open"  biomedical literature.

    Besides,  at last count, over forty US and several
hundred foreign patents are issued in this area.
Probably most work at least some--few if any have been published.

Treatment Agents

A) Antiandrogens: E.g.: Proscar, Cyoctal, spironolactone.

     Poorly-effective alone.  Mainly useful as adjuvants to
other therapy where they 1) make it work better 2) Help
prevent tolerance.  Every few years, a new antiandrogen will
be presented as the ultimate "solution for balding". This has
yet to work out.  E.g., clinical trials with cyoctal,
arguably the most potent topical antiandrogen, were
terminated because of lack of effectiveness.

    We'll see about proscar ( the weakest one ).  Early reports
suggest it works about as well as topical spironolactone or cyoctal
( e.g., about half of patients show a 10% or greater number of
hairs on their heads after a year on treatment ).   Because
Proscar is already FDA-approved for prostate enlargement,
Merck will have an easier time getting FDA opproval for it.

    BTW, I have prime patents in this area ( for growth stimulators
plus antiandrogens ).   In fact, because of the publication of our
patents, the combination of a hair growth stimulator plus and
antiandrogen is now " obvious " and thus unpatentable.   I
sure wish antiandrogens worked better.

    Possible explaination: Male hormones only initiate balding.
Further, whatever hormones do seems to be mostly irreversible.
The main damage to the hair follicle seems to be done by other
factors, especially immunological.

B) Direct Hair Growth Stimulators

There are two main kinds:

1) Agents like minoxidil.   These mimic the transmitter
substance nitric oxide, which tells hair to grow and not fall out.

2) SODases and related agents.  These destroy the tramsmitter
substance superoxide, which tells hair to stop growing
and fall out.

Examples

Nitroxides: Minoxidil, nicorandil, NANO, etc.

     Some of these are blood vessel dialating hair-growth
stimulators. OTOH, most dialating agents don't stimulate hair
growth, nor do all these agents dialate blood vessels.
So, vessel dilatation is not _directly_ related to
hair growth stimulation.

     Possible explaination: Nitrovasodialators mimic natural
substance mediating _both_ dialation and hair growth.  Best
candidate: nitric oxide ( aka, EDRF ), a ubiquitous
transmitter which has identical effects to minoxidil on blood
vessels.

Superoxide Dismutase Mimetics.

    These include Iamin, " trichomin" (Procyte corporation),
Copper-Binding Peptide (Procter and Gamble),  TEMPOL,
others (In the late 70's, we found that SODase prevents
stress loss in experimental animals ).   Another copper-binding
peptide SODase hair-growth stimulator made from soy protein
was just patented.  Other radical scavengers also effective
( e.g., various US and foreign patents-- including some to us.)

     BTW, the US patent office just awarded me the prime
patent for SODases in hair loss.

     Further, this technology is so mature that the Procter
and Gamble corporation has a US patent on a SODase inhibitor
( Diethyldithiocarbamate ) to PREVENT hair growth.

     SODases destroy superoxide free radical: Superoxide
reacts with nitric oxide ( the putative "natural" minoxidil )
to produce other toxic free radical products.  OTOH, in many
systems, superoxide is a messenger substance in its own right.
In such systems, it ofter opposes the action of nitric oxide.
So, SODases may work by increasing nitric oxide levels or
more directly.

     Alternately, such agents may interfere with
the immunological component in hair growth.  Active oxygen
species are the most important mediators of cell-mediated
immunity.   BTW,  a mild infiltrate of immune cells
develops around the normal follicle as the hair cycle progresses.
This may be the source of the superoxide that tells hair to
stop growing.

     Significantly,  nitric oxide and superoxide have
opposing "yin-yang" effects on a number of bodily systems.
Examples include blood-vessel dialatation ( nitric oxide
dialates, superoxide constricts ), blood clotting, etc.

      These paired agents may be the most ubiquitous
transmitter substances around.   You can explain a lot by
assuming that nitric oxide is the transmitter that initiates
and maintains hair growth, while superoxide both inhibits
hair growth and causes hair to transition from the growth
phase to the loss phase.
__________________________________________________________

     I am an MD,PHD pharmacologist who practices dermatology
and does hair-loss research.  Repost, but please leave the
credit.

BTW: Please address general questions to the newsgroup so that
I don't have to keep answering the same ones over and over.


Peter H. Proctor, MD,PhD
Suite 1616, 4126 SW Freeway
Houston, TX 77027
(713) 960-1616
pproctor@sam.neosoft.com

Shameless Plug: Send your surface mail address and
we'll tell you about our program for treating hair loss.
Sorry, our stuff is not in electronic form yet.


c 1995 Peter H. Proctor



From owner-ageing@net.bio.net Thu Sep 21 23:00:00 1995
Path: biosci!LEX.LCCC.EDU!rcb1
From: rcb1@LEX.LCCC.EDU (Ron Blue)
Newsgroups: bionet.molbio.ageing
Subject: Forwarded: aspartame a real danger?
Date: 22 Sep 1995 05:51:53 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 255
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.3.89.9509220840.L29773-0100000@lex.lccc.edu>
References: <43shgi$n42@news.euro.net>
NNTP-Posting-Host: net.bio.net

From betty@pd.org Fri Sep 22 07:57:28 1995
Date: Thu, 21 Sep 1995 14:50:10 -0400 (EDT)
From: Betty Martini <betty@pd.org>
To: Ron Blue <rcb1@lex.lccc.edu>
Subject: Re: Tinnitus FAQ Pointer (fwd)



Betty Martini
Domain:  betty@pd.org
UUCP:  ...!emory!pd.org!betty

---------- Forwarded message ----------
Date: Wed, 20 Sep 1995 14:57:00 -0400
From: Betty Martini <betty@noel.pd.org>
Newgroups: alt.support.tinnitus, alt.rock-n-roll.hard,
    alt.sci.physics.acoustics, misc.health.alternative, rec.audio.misc,
    rec.audio.pro, rec.music.makers, rec.music.misc, sci.med,
    sci.med.dentistry, sci.med.nutrition
Subject: Re: Tinnitus FAQ Pointer

I'm replying to several inquiries I've had about aspartame and tinnitus, 
including this one, because of a previous post I did explaining that 
aspartame triggers tinnitus.  Now that didn't mean that aspartame is the 
only cause, of course, it simply meant that we see it frequently.  
Aspartame use to be in 300 products, and then 600 products, but now the 
patent has expired and it is now in 5000 products and climbing!  Some 
people really live a nightmare with this problem, and are very happy to 
learn of this trigger because when it is from aspartame it vanishes as 
soon as the toxin is eliminated.  Also, even if the tinnitus was from 
another source, it might not be easy to treat if the patient was not 
warned that a product they were using that triggers it by itself will
aggravate the problem.  And lastly, nobody should use this anyway because 
it is a chemical poison.  It is not even a diet product.  It says in the 
Congressional Record, S5511, May 7, 1985, the following:

"Aspartame has been demonstrated to inhibit the carbohydrate-induced 
synthesis of the neurotransmitter serotonin (Wurtman affidavit).  
Serotonin blunts the sensation of craving carbohydrates and thus is part 
of the body's feedback system that helps limit consumption of 
carbohydrate to appropriate levels.  Its inhibition by aspartame could 
lead to the anomalous result of a diet product causing increased 
consumption of carbohydrates."

Translation:  Use "diet" products sweetened with aspartame and get fat!
Aspartame was discovered by a Searle chemist testing a peptic ulcer drug, 
and it was intended to be a "drug".  It is not a food additive; consider 
possible reactions when mixed with other drugs.  It was kept off the 
market for 16 years because it caused brain tumors and grand mal seizures 
in lab animals, and thats what it is doing to the population now - and 
thats just for starters.  The FDA admits to 92 documented symptoms from 
coma to death.  Diabetics who it is pushed on should be warned it has the 
component of methanol (wood alcohol) and this is a severe metabolic poison
disastrous to the health of a diabetic, and the other components are just 
as dangerous.

In my last post I quoted two books that link aspartame to tinnitus, and 
said that most people who research and write about aspartame know it 
triggers tinnitus.  I picked up a new book yesterday called NEW CHOICES 
IN NATURAL HEALING EDITED BY Bill Gottlieb, Editor-in-Chief, Prevention 
Magazine Health Books.  I happen to look up NutraSweet in this book last 
night just to see if it was listed and here is what it says: Page 45

"Perhaps even more significant is the possible danger of many common food 
additives.  Aspartame, the artificial sweetener sold as NutraSweet and 
Equal, can cause headaches and migraines, rashes, ringing ears, 
depression, insomnia and loss of motor control, according to a study by 
the Food and Drug Administration."

I'm calling attention to his remark about "ringing ears".  It is a known 
fact that aspartame triggers tinnitus, as well as other ear problems. 
This book has a copyright date of 1995 by Rodale Press.

After my post I got a few inquiries that wanted more information, and 
requested references to double-blind studies.  I should warn you that the 
studies funded by Searle (Monsanto bought Searle in l985) are flawed and, 
in my opinion, useless.  Dr. Arthur Hull Hayes, head of the FDA, 
over-ruled his own board of inquiry that said not to approve aspartame 
and went to work for Searle's PR firm and refused to speak to the press 
for 10 years.  It was requested that U.S. Attorney Sam Skinner indict 
Searle because of these flawed studies (like rats being resurrected on 
paper after they were declared dead!) but instead he went to work for 
Searle's law firm defending the case as did the U.S. Attorney after him.  
The statute of limitations gave out and Searle got away with putting a 
poison, even though its a sweet poison, in the marketplace.

Since many in this newsgroup insisted on medical documentation I notified 
Dr. H. J. Roberts who is considered the world expert on aspartame.  He 
has written books on the subject and many publications that were published 
in peer review journals.  He is a Board-certified practicing internist 
and an internationally known medical consultant and researcher.  He is 
listed in Who's Who in America, Who's Who in The World, Who's Who in 
Science and Engineering, and The Best Doctors in the U.S.

He is on the Active Staff of Good Samaritan Hospital and St. Mary's 
Hospital (West Palm Beach), Director of the Palm Beach Institute for 
Medical Research (since l964) and a member of many prestigious medical 
and scientific organizations - including the Endocrine Society and the 
American Academy of Neurology.  He has authored nine acclaimed books, 
three being nominated for a Pulitzer Prize.

I requested that Dr. Roberts write a report on aspartame and tinnitus and 
he most graciously forwarded me the attached, in the hope that it would 
warn those with tinnitus, as well as others, of the danger of using 
aspartame.  We hope you will copy it and warn others with this problem.

           PROFESSIONAL OPINION OF H. J. ROBERTS, M.D., F.A.C.P.,
           F.C.C.P. CONCERNING THE USE OF PRODUCTS CONTAINING
           ASPARTAME (NUTRASWEET@) BY PERSONS WITH EAR AND
           EQUILIBRIUM PROBLEMS

It is my opinion that individuals who consume products containing aspartame,
including drugs and supplements,  should avoid them when no specific 
cause can be found for these symptoms:

	*"Ringing" or "buzzing" of the ears (tinnitus) ... some-
	   times described as hissing humming or whistling
	*Marked intolerance to noise
	*Impairment or loss of hearing
	*Marked unsteadiness or dizziness

The same precaution is reasonable for persons in whom these complaints 
are due to other disorders because they could be aggravated by aspartame, 
even in minimal amounts.

These corporate-neutral suggestions are based on considerable 
observation, research and correspondence published in more than a score 
of articles and two books:

    *	ASPARTAME (NUTRASWEET@): IS IT SAFE?  (Philadelphia, The Charles
        Press)
    *   SWEET'NER DEAREST:  BITTERSWEET VIGNETTES ABOUT ASPARTAME
        (NUTRASWEET@) (West Palm Beach, Sunshine Sentinel Press,
        P. O. Box 17799: 1 800-814-9800: Fax 407-832-2400)

I also have reviewed these and related problems in my two-cassette talk, 
IS ASPARTAME (NUTRASWEET@) SAFE?  A MEDICAL, PUBLIC HEALTH AND LEGAL 
OVERVIEW  --1995 (Sunshine Sentinel Press).

These represent hard - won insights in the trenches of a medical 
practice. Patients and consumers should not be misled by the "negative" 
conclusions of flawed studies sponsored by vested interests.

There is no bias or malice intended against any company, distributor, 
researcher or professional who may hold contrary views.

                  THE ROLE OF ASPARTAME

Each of these components of aspartame -- phenylalanine; aspartic acid; 
the methyl ester, which promptly becomes methyl alcohol or methanol -- 
and their multiple breakdown products after exposure to heat or during 
prolonged storage is potentially toxic to the brain and inner ear.  These 
organs are uniquely vulnerable to metabolic disturbances and neurotoxins 
because of their unique metabolic requirements.  

                      REPRESENTATIVE CASE REPORT

	A 30-year-old woman drank five or more cups or glasses of
	aspartame beverages daily for 17 months.  She experienced
	ringing and pain in both ears, dizziness, a severe headache,
	and considerable loss of hearing in the left ear by audio-
        metric studies.  When brain tumor was ruled out by CT scans,
        otology and neurology consultants made the diagnosis of
        Meniere's disease.  The patient deduced that the aspartame
        drinks were responsible because she could predictably
        reproduce these symptoms on rechallenge with them.

                            A N   O V E R V I E W

In my publications, and in testimony to Congress and an FDA advisory 
group. I have expressed the belief that the current wholesale ingestion 
of aspartame products by over half the adult population constitutes a 
probable "imminent public health hazard."  My concern is bolstered by (1) 
evidence that these products may play a causative or aggravating role in 
many other medical disorders (including headaches, dizziness, confusion, 
impaired vision, convulsions, and probably brain tumors), (2) the flawed 
nature of most "scientific" studies being used to prove the alleged 
safety of these products, and (3) reports of serious reactions 
volunteered to the FDA by over 7,300 irate consumers.  

In the present context, these statistics are pertinent.

  *In my earlier report on 551 aspartame reactors (the data base is now 
   much larger), dizziness was a major problem in 217 (39%), tinnitus in
   73 (13%), severe intolerance for noise in 47, and marked impairment in
   hearing in 25.

  *The FDA (as of August 1995) had received complaints about dizziness
   and problems with balance from 737 consumers, and a change in hearing
   from 36.

  *The American Tinnitus Association found that the cause of tinnitus in
   18,000 suffers was unknown in one-third.

These complications tend to be magnified in persons with unrecognized 
hypothyroidism (underactive thyroid), hypoglycemia (low blood sugar 
reactions), diabetes, hypertension, reactions to MSG, treatment with 
aspirin and other drugs that can irritate the auditory nerves, and 
problems associated with aging.  They become compounded by the threat of 
falls and driving accidents.

I welcome reports of such reactions, and results of the "no aspartame 
test", for our independent registry.  A 9 page survey questionnaire can 
be obtained by calling (407) 832-2408, or fax 407 832-2400.  

I have also expressed concern that aspartame products might be 
accelerating Alzheimer's disease.  The details appear in my 
just-published book, DEFENSE AGAINST ALZHEIMER'S DISEASE:  A RATIONAL 
BLUEPRINT FOR PREVENTION (Sunshine Sentinel Press - address listed 
above).

                         H. J. Roberts, M.D., F.A.C.P., F.C.C.P.

@1995

I might add that we have Dr. Roberts' form by email.  We also ask that 
you send us your case history as well and the FDA because they state 
that only 1% actually report serious problems.  And even with them not 
accepting some complaints and referring others to the Aids Hotline, 
there were still 10,000 complaints on their April, 1995 report, almost 
80% of all reports to the FDA on additives.

This is a very serious problem folks.  Dr. Roberts did not mention what 
the breakdown products are but methanol converts to formaldehyde and 
then formic acid (ant sting poison) causing metabolic acidosis.  The
phenylalanine breaks down to DKP (a brain tumor agent).  So unless you 
are looking for free embalming I would not consume aspartame in any form.
You cannot heat aspartame because of these breakdown products, but the 
FDA forgot they have mentioned this in the past and have now approved it 
for baked goods, and many times aspartame is contained in baked foods in 
the bakery of your local grocer as well restaurant food.  Pharmacists 
are complaining about it being in drugs from cholesterol lowering drugs 
to antibiotics and many times cause the very problem the drug is suppose 
to cure.  Be careful.

The soda pop companies sent diet pop to the troops in the Persian Gulf 
and they sat 8 weeks in the 120 degree Arabian sun.  If you want to 
review my report on Desert Storm Syndrome and receive other information 
on aspartame including the history and case histories from the 
auto-responder please email me for information.  And please warn others.

            Betty Martini        Operation Mission Possible   	


	



Betty Martini
Domain:  betty@pd.org
UUCP:  ...!emory!pd.org!betty





From owner-ageing@net.bio.net Fri Sep 22 23:00:00 1995
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!EU.net!newsfeed.internetmci.com!howland.reston.ans.net!news.sprintlink.net!in2.uu.net!newstf01.news.aol.com!newsbf02.news.aol.com!not-for-mail
From: mikemldvn@aol.com (MikeMldvn)
Newsgroups: bionet.molbio.ageing
Subject: Cancer and Suicide Among Older Men
Date: 22 Sep 1995 21:48:46 -0400
Organization: America Online, Inc. (1-800-827-6364)
Lines: 240
Sender: root@newsbf02.news.aol.com
Message-ID: <43vp1u$hli@newsbf02.news.aol.com>
Reply-To: mikemldvn@aol.com (MikeMldvn)
NNTP-Posting-Host: newsbf02.mail.aol.com

Cancer and Suicide Among Older Men

   (This is a long posting concerning men, cancer, and suicide.  I am also
posting the message's substance to forums in America OnLine and to
Internet newsgroups and mailing lists where it might be appropriate. 
Because of its length, I suggest that anyone intrigued by the first
paragraph or so *save* the posting to disk and read it offline by word
processor, when convenient.  For readers' protection, I usually preface
postings such as this with the caveat that I am a layman, and my expertise
in medicine and all other healing arts is limited to peeling the backing
off a Band-Aid.  However, I was a *hotline* volunteer in a suicide
prevention center for a couple of years during *Viet Nam*.) 

   Every once in a while I am reminded that suicide is a private, silent
and, at times, profound gut reaction to adversity in many men who, like
me, are in their 8th decade or older.  The statistics on suicide show that
the suicide rate for white men increases with age, and that white men over
65 are about 4 or 5 times more likely to commit suicide than older white
women.  Illness, loss of wife or other life partner, family and financial
difficulties, alcololism, and comparable difficulties intensify a man's
urges toward wanting out. 

   As a rule, elderly men are suspicious of suicide prevention agencies
(and even distrust family and close friends when it comes to suicide), and
will often resist being drawn into the *prevention* process.  In no
uncertain terms they feel that, "It's _my_ business and I'll take care of
it."  Yet, we older men do want to understand why we can feel so badly
that killing ourselves is the only answer but, (pardon the pun) we
wouldn't be caught dead checking a book on the subject out of the library,
worse yet, being seen reading it.  So  unintentionally coming across a
posting on old man suicide while scanning the Internet is maybe OK.  
  
***

   I summarized this *professional* article a few years ago in America
OnLine's *SeniorNet* because I thought it was well-written and
understandable.  I repeated the posting recently in the Seniornet *men's*
folder in the light of recent postings there by other men in which they
welcomed *health* related discussions that that didn't deride or sneer at
others.  Also, there had been quite a few new members since the article
was last posted and discussed. Anyhow, in summary:

*** 

   An article *Suicide and Cancer in Late Life* (Vol. 41, No 12, December
1990) published in the journal *Hospital and Community Psychiatry*
concerned suicide among older men who were, or suspected that they were,
in advanced stages of cancer.  The article's authors are Yeates Conwell,
M.D., Eric D. Caine, M.D., and Kurt Olsen, Ph.D.  Drs. Conwell and Caine
hold professorships and Dr. Olsen holds an assistant professorship at
prestigious academic or health care institutions.  
   
   The article's Abstract, in full, states:  *In a controlled
psychological autopsy study of suicide in late life, eight cases in which
the victim's belief that he had cancer played a major role in the decision
to end his life, were examined.  All victims were men.  The majority had
major affective disorders, but none had been seen in mental health care
settings.  Other common characteristics were an active relationship with a
primary physician, numerous losses, prior experience with cancer or
debilitating disease, and a rigid, self-sufficient personality.  The cases
illustrate the complex determinants of suicidal behavior in the elderly
and suggest preventive strategies.*

   Physical illness is a commonly cited risk factor for suicide,
especially in late life.  Of the physical illnesses associated with
suicidal behavior, cancer stands out.  (Researcher's name) estimated that
malignant neoplasm was present 20 times more often in his sample of
suicide victims than expected in the general population, and (researcher)
studying suicide and accident victims over age 50, found cancer was
significantly more common among those who took their own lives.

   In addition, large scale epidemiological studies have found cancer
patients to be at significantly higher risk for suicide than the general
population.  Cancer has a special psychological significance in our
culture, where it is associated with pain, suffering, and death. 

   The 8 men:  One of the 8 was 50 years old and separated, a 71 and a 76
year old were married, and the remaining 5, in their mid to late 70s, were
widowed.  The psychological autopsy included interviews with relatives and
friends, and reviews of medical records.  Informants described the men as:
 Mr. A:  Very robust.  Strong-willed.  Loved to be around people, but had
a short fuse.  Very domineering. ---  Mr. B: Strict. Precise. Honest. 
Friendly independent. Quiet. Withdrawn.  --- Mr. C:  Self-sufficient,
independent, liked to be needed.  ---   Mr. D:  Isolated and dissatisfied.
 Just couldn't take any more disappointments. ---  Mr. E:  An extremely
stoic, solid guy who never complained. Avoided conflict whenever possible.
---  Mr. F:  Jovial, outgoing, but couldn't make decisions. ---  Mr. G: 
Friendly, but reserved.  Obsessed with colostomy care.  ---   Mr. H: 
Conservative, emotionally constricted.

    Psychological diagnosis:  Five of the 8 men were diagnosed as *Major
depression, single episode.*  One, a widower, was *Alcohol abuse, in
remission.*  Dependence on alcohol or other intoxicants were indicated for
3 men and 1 had no diagnosis.  The men were selected for this report
because of their expressed concerns about cancer.  Their experience with
cancer is quoted as follows:  Mr. A:  Pain due to cancer, fear of
treatment. ---  Mr. B:  Physical decline associated with belief that his
stomach was *loaded with cancer.*  ---  Mr. C:  Wife died of uterine
cancer in 1982;  physical decline associated with belief that the colon
cancer (he had in 1983) was terminal,  *he was fatalistic.*  ---  Mr. D: 
Somatic preoccupation: *I might have cancer, but nobody's cutting me
open.*  ---  Mr. E:  Close friend recently died after one-year
hospitalization; increasing abdominal pain;  was convinced *something was
seriously wrong.*  ---  Mr. F:  First wife died of cancer in 1973;  cousin
died of cancer in 1987;  physical decline with diarrhea; *he thought he
had cancer.*  ---  Mr. G:  Wife died of cancer in 1987; deterioration of
health associated with belief that he had recurrent cancer.  ---  Mr. H: 
Wife died of cancer in 1983;  discovered blood in his stool and assumed he
had recurrent cancer.  ---  Mr. H survived an attempt at suicide and was
included in the study because he was a unique source of data.

Three of the cases were presented in detail: Mr. B, Mr. C, Mr. H.

   Case 1.  Mr. B was a 77 year-old who killed himself with a gunshot to
the head.  His wife had died in 1969 of multiple sclerosis, for which he
had provided assiduous care at home. Despite subsequent losses, including
the death of his only son and a favored nephew and his daughter's
diagnosis with multiple sclerosis, Mr. B functioned well socially. 
However, his physical state was progressively more compromised by
emphysema.  Mr. B stated repeatedly to his friends that he would not
tolerate becoming a burden on others as his wife had been.  *When I get
that way,* he said, *I will take the bullet.*

   During his last several months of life, Mr. B became more withdrawn. 
After a flu-like illness, he complained increasingly of stomach and head
pains, sleep and appetite disturbance, and anxiety.  His friends reported
that he seemed preoccupied, and he revealed to them the day before his
death that he thought his stomach was *loaded with cancer.*  There were no
other indications of impaired reality testing.  He had no prior history of
suicidal behavior or psychiatric illness or concerns, and he drank
infrequently.

   Mr. B had always avoided doctors, but with the apparent change in his
health during his last weeks, he was persuaded by family and friends to
see a physician.  An appointment was scheduled for the day of his death. 
When a friend arrived at his home to take him to the appointment, she
found him dead.  A physical autopsy was not performed. Therefore, although
Mr. B's symptoms and course were consistent with a single episode of major
depression, (we) were unable to specify the relationship between his
affective disorder and his physical condition.

   Case 2:  Mr. C was a 77-year old widowed white man who had lived alone
since his wife's death in 1982 after a protracted struggle with uterine
cancer.  After a brief and appropriate grief he began to travel, an
activity he enjoyed until one year later, when he received a diagnosis of
cancer of the colon.  He underwent treatment but refused the recommended
colostomy and developed incontinence of both urine and stool.  Therefore,
due to incontinence, chronic obstructive pulmonary disease, cataracts, and
hearing deficits, he became increasingly withdrawn and restricted in his
activities.  He had no history of suicidal behavior or psychiatric
contacts, and he rarely drank.

   Throughout life Mr. C had made such comments as, *When I get old and I
can't do for myself, put a gun to my head.*  During the last four months
of his life he rapidly declined.  He had pronounced anhedonia, anorexia,
weight loss, and loss of concentration and energy.  Four days before his
death, he saw his primary physician at his daughter's insistence. 
Impressed by Mr. C's deterioration, the physician scheduled a hospital
admission for further evaluation.  The next day Mr. C killed himself with
a gunshot to the head.  His family believed that he took this action with
the perception that he was terminally ill with metastatic colon cancer. 
An autopsy showed only pulmonary emphysema; there was no evidence of
recurrent tumor.  Our consensus diagnosis was major depression, single
episode, without psychotic features.

   Case 3.  Unlike the preceding subjects, Mr. H failed in his attempt to
take his life.  He provided the following history during an inpatient
hospitalization after his suicide attempt.  Mr. H was a 78-year old white
man who had moved from his home to a senior citizen's apartment complex in
1986 following a series of losses  --  his wife's death in 1983 from
metastatic cancer, a right hemispheric stroke with residual hemiparesis,
and a surgical resection for treatment of bowel cancer in 1985.  He had no
prior history of suicide attempts or psychiatric illness.

    One week before his suicide attempt, Mr. H discovered blood in his
stool.  Concluding that his cancer had returned and that he would die
following a protracted and painful course, he carefully planned his death.
 On the morning of his attempt, Mr. H left his family a note and money for
anticipated expenses, drove his car to a municipal parking lot, and shot
himself in the left side of the chest.  The bullet, which exited at the
tip of the left scapula, narrowly missed his heart.  He was discovered
several hours later.  During the subsequent hospitalization, his
hematochezia was diagnosed as bleeding hemorrhoids.  Mr. H was without
somatic delusions and gratefully accepted the fact that there was no
cancer recurrence.

   Discussion (excerpts): The conclusion drawn here must be considered
cautiously, in light of the small sample size and retrospective
methodology.  In addition, we can define no appropriate subject group for
direct comparison.  The sample included patients with cancer and those
with the unverified belief that they had the illness.  Our concern is not
solely whether cancer places an individual at risk for suicide, but
whether the belief or perception that one has a terminal illness
constitutes such a risk.  We seek to understand how these individuals may
have been predisposed to their apparently lethal beliefs and to recognize
the implications of the cases for clinical practice and suicide
prevention.

   A second link between suicide and the belief that one has cancer may be
provided by the observation that loss and a prior experience with cancer
or other debilitating chronic illness were common factors among our cases.
 Three of the eight subjects had a prior personal history of colon cancer
(Mr. C, G, and H), and the wives of four had died of cancer (Mr. C, F, G,
and H).  Two others (Mr. B and E) had lost a wife or close friend to other
debilitating diseases.  The effects of chronic and deteriorating illnesses
were, therefore, familiar to most subjects and were feared.  As Mr. H
stated, *I don't want to die a lingering and painful death like my wife.* 
The fear of cancer was far more prominent than its reality.

   Conclusion: (excerpted)  The understanding of suicide in late life must
go beyond the presence or absence of associated physical or psychiatric
illness to include considerations of coping style, long-term functioning,
and personal values.  Physicians must not be quick to adopt the view that
suicide is, in any instance, a simple matter.  Rather, as these cases
illustrate, suicide is a multifactorial process.  Although superficially
understandable, these deaths caricature *rational suicide*:  the victims
often were clinically depressed, and they uniformly exaggerated the
medical significance of their symptoms.

   Early in the course of their medical school education physicians should
be trained to diagnose and treat depressive disorders in late life, being
particularly alert for atypical somatic presentations in previously
high-functioning, non-psychiatric patients.  Furthermore, our training
centers should reexamine their commitment to the patient-centered
approach.  In this age of technological medicine and cost containment, the
clinician must be alert to the latent content of our interactions with
patients.  To avoid the elaboration and distortion that characterized the
thinking of the eight men we described, clinicians must actively elicit
their patients' perceptions, apprehensions, and experiences relating to
cancer and other debilitating illnesses.  They must take time to explore
their patients' fears regarding loss of autonomy and vigor and increase of
pain.

   Finally, on the scale of national health policy, we must educate the
general public about the relationship of depressive disorders,
hypochondriasis, and suicide risk; demythologize cancer, and establish
reimbursement mechanisms that value the personal, time-consuming
interchanges between the primary care physician and the patient through
which psychotherapeutic intervention can be made.
                                                   ***

From owner-ageing@net.bio.net Fri Sep 22 23:00:00 1995
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!EU.net!howland.reston.ans.net!vixen.cso.uiuc.edu!uchinews!news.luc.edu!news
From: efasco <yrutman@orion.it.luc.edu>
Newsgroups: bionet.molbio.ageing
Subject: RE: THINNING HAIR?....MINOXIDIL USERS?...
Date: 23 Sep 1995 19:19:19 GMT
Organization: TRICHOGEN
Lines: 5
Message-ID: <441mjn$3dk@artemis.it.luc.edu>
NNTP-Posting-Host: 147.126.58.44
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.2b5 (Windows; I; 16bit)

Now available in U.S.  PENTADECANOIC ACID GLYCERIDE and FABAO FORMULA.  World's 
leading treatments.  #1 in Japanese clinical studies. When used alone or in 
combination with minoxidil, will charge up your hair growth by 300%.  Featured on 
CNN, NEWSWEEK, NEW YORK TIMES.  For free info, please call 1-800-555-8655.


From owner-ageing@net.bio.net Fri Sep 22 23:00:00 1995
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!EU.net!news.sprintlink.net!dispatch.news.demon.net!demon!mail2news.demon.co.uk!howl.demon.co.uk
From: Jenny <Jenny@howl.demon.co.uk>
Newsgroups: bionet.molbio.ageing
Subject: Advice please
Date: Sat, 23 Sep 95 07:17:01 GMT
Organization: -
Lines: 8
Message-ID: <811840621snz@howl.demon.co.uk>
Reply-To: jenny@howl.demon.co.uk
X-NNTP-Posting-Host: howl.demon.co.uk
X-Newsreader: Demon Internet Simple News v1.29

I hvae been searching for newsgroups which deal with coping with the
effects of ageing, dealing with elderly parents, dealing with stroke
or stroke support groups, carer support groups etc.  So far I have not
found anything.  These newsgroups may exist but my server doesn't
presently carry them. Anybody know of any please?
-- 
***** Jenny *****

From owner-ageing@net.bio.net Fri Sep 22 23:00:00 1995
Path: biosci!UCHSC.EDU!Ed.Krug
From: Ed.Krug@UCHSC.EDU (Edward Krug)
Newsgroups: bionet.molbio.ageing
Subject: Old grafting test of Hayflick limit
Date: 23 Sep 1995 01:55:29 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 13
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.ULT.3.91.950923024322.16598A-100000@essex.UCHSC.edu>
NNTP-Posting-Host: net.bio.net


Help.  I need to track down the scientific community's verdict on the 
experiments where a patch of distinct skin was serially passed to young 
mice (?) to attempt to determine if the skin stays young if it is always 
attached to a young animal, or if it ages even though it's blood supply 
comes from a young animal.
	I seem to recall some discussion that there was no clear 
conclusion because the graft became infiltrated with younger host cells.
	I could find the orginal article on Medline, but finding the 
follow on commentary and overall conclusion is difficult.
Thanks, in adance,
Ed Krug


From owner-ageing@net.bio.net Fri Sep 22 23:00:00 1995
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!EU.net!howland.reston.ans.net!vixen.cso.uiuc.edu!uchinews!news.luc.edu!news
From: efasco <yrutman@orion.it.luc.edu>
Newsgroups: bionet.molbio.ageing
Subject: RE: THINNING HAIR?....MINOXIDIL USERS?...
Date: 23 Sep 1995 19:19:20 GMT
Organization: TRICHOGEN
Lines: 5
Message-ID: <441mjo$3ht@artemis.it.luc.edu>
NNTP-Posting-Host: 147.126.58.44
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.2b5 (Windows; I; 16bit)

Now available in U.S.  PENTADECANOIC ACID GLYCERIDE and FABAO FORMULA.  World's 
leading treatments.  #1 in Japanese clinical studies. When used alone or in 
combination with minoxidil, will charge up your hair growth by 300%.  Featured on 
CNN, NEWSWEEK, NEW YORK TIMES.  For free info, please call 1-800-555-8655.


From owner-ageing@net.bio.net Sat Sep 23 23:00:00 1995
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!EU.net!howland.reston.ans.net!news.nic.surfnet.nl!news.wau.nl!usenet
From: Thorsten Jabs <thorsten.jabs@medew.fyto.wau.nl>
Newsgroups: bionet.molbio.ageing
Subject: Re: Oxidative stress as a cause for ageing
Date: 24 Sep 1995 16:44:10 GMT
Organization: fyto.wau.nl
Lines: 24
Message-ID: <4441sq$qu9@Trex.IenD.wau.nl>
References: <Pine.SCO.3.91.950921134107.29268A-100000-100000-100000-100000@skull.cc.fc.ul.pt>
NNTP-Posting-Host: flex180.dbh.wau.nl
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.1N (Windows; I; 16bit)
To: qjpcbraz@cc.fc.ul.pt

Jorge Braz <qjpcbraz@cc.fc.ul.pt> wrote:
>	I am looking for any information about the reactions of oxygen 
>radicals (o2.-, HO., O1, H2O2) with the DNA bases especially the rate 
>constants and the products percentages of this reactions.
>			 Jorge Braz
Hi Jorge,

could you please forward your results to me.

Thanks a lot,

Thorsten

Dr. Thorsten Jabs		email:	thorsten.jabs@medew.fyto.wau.nl
Dept. of Phytopathology		tel:	+31-8370-8-3135 (fax: -3412)
Wageningen Agricultural University	+31-317-48-3135 from october 95
P.O. Box 8025
NL-6700 EE Wageningen
The Netherlands

Plant-pathogen interactions; signal perception and transduction; 
oxidative burst; systemic acquired resistance; hypersensitive cell death: 
OML means Orchestral Manoeuvers in the Light


From owner-ageing@net.bio.net Sun Sep 24 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!tank.news.pipex.net!pipex!btnet!uunet!in2.uu.net!library.erc.clarkson.edu!rpi!rebecca!gk1702
From: gk1702@csc.albany.edu (KRISHNA GOPALA S)
Newsgroups: bionet.molbio.ageing
Subject: EM Work!
Date: 25 Sep 1995 02:43:48 GMT
Organization: The University at Albany
Lines: 66
Distribution: na
Message-ID: <445514$f0m@rebecca.albany.edu>
NNTP-Posting-Host: eve.albany.edu


            ********************************************************
             Do  You  Have  Work  On  Transmission, Scanning, Cryo-
            Electron Microscopes, Elemental Analysis and Image
            Analysis?
            *********************************************************
        
            I am a Certified Electron Microscopist from V.A.Hospital,
            Albany, NY and I have two years experience on specimen    
            preparation, processing for Transmission, Scanning, Cryo-
            Electron Microscopes, Ultramicrotomy, Photographic techniques.
            If you send your specimen samples, I can process them and
            take very nice pictures under Transmission, Scanning Electron
            Microscopes and also perform elemental analysis under SEM
            and mail them to you.
            I charge very less money per sample comparative to other
            people.  I charge $50 per sample.
            I can process any plant, animal specimens for Electron
            Microscpy study.  Please send $50 cash or check and specimen
            sample to Mr.Krishna, 248 Shakerrun Apts, Albany, NY-12205.
 
             Please E-mail your questions to:
                  
                gk1702@ix.netcom.com
            
            Approximate time for specimen preparation, processing 
            for TEM and SEM:

            Specimen processing time for TEM      24 Hours
            & SEM:                                     
            Ultramicrotomy, thick, thin
            section slides preparation,
            positive, negative staining
            techniques, observation under
            Transmission electron microscope
            depending upon microscope time      
            and photography techniques            1 to 2 days

            Specimen preparation for SEM
            i.e. sputter coating or sputtering
            or carbon coating, observing under
            SEM and taking pictures               1 to 2 days
   
            I need to pay for chemicals, electron microscopy time,
            for purchasing film for both TEM and SEM etc that is
            why I am charging $50 per specimen.  I apologize I
            mentioned $10 per sample in my last posting and it
            is not feasible for me.

            P.S.: This is not scam or some thing nonsense. 
                  I completed B.S. in Biology and Chemistry,
                  M.S. in Biology, Master of Philosophy in Biology,
                  one year intensive training on Electron Microscopy
                  at The School Of Electron Microscopy, Veterans
                  Hospital, Albany, NY and I am a certified
                  computerprogrammer.  I have strong ambition to
                  utilise my Electron Microscopy skills in the
                  field of Biology and Medicine.  This way, I
                  can fulfil my ambition to become a diagnostic
                  Electron Microscopist and inturn I will be 
                  useful to The School Of Electron Microscopy,
                  V.A.Hospital, Albany, NY.
            

           *************************************************************
                    

From owner-ageing@net.bio.net Sun Sep 24 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!swrinde!tank.news.pipex.net!pipex!news.sprintlink.net!in2.uu.net!hoho.quake.net!xdcrlab.com!user
From: xdcrlab@quake.net (Mike Davis)
Newsgroups: bionet.molbio.ageing
Subject: Re: Oxidative stress as a cause for ageing
Date: Mon, 25 Sep 1995 13:11:23 -0700
Organization: XdcrLab
Lines: 20
Distribution: world
Message-ID: <xdcrlab-2509951311230001@xdcrlab.com>
References: <Pine.SCO.3.91.950921134107.29268A-100000-100000-100000-100000@skull.cc.fc.ul.pt>
NNTP-Posting-Host: xdcrlab.com
X-Newsreader: Value-Added NewsWatcher 2.0b24.0+

In article
<Pine.SCO.3.91.950921134107.29268A-100000-100000-100000-100000@skull.cc.fc.ul.pt>,
Jorge Braz <qjpcbraz@cc.fc.ul.pt> wrote:

>         I am looking for any information about the reactions of oxygen 
> radicals (o2.-, HO., O1, H2O2) with the DNA bases especially the rate 
> constants and the products percentages of this reactions.
 
Jorge,

You might try the Oxygen Therapy web site, many abstracts and a few
papers, a few hundred listings.  I recall Ramasarma's '94 paper mentioned
a bacterial DNA protective protein that when oxidized folded over the DNA
to protect it.  I maintain a link on my SpringBoard website, the location
may be changing soon.

-- 
Melatonin.Folate.Trypto,Articles,Discnt.Suplmnt.Sources,Cool.Stuf
The.Buffalo.SpringBoard:> http://www.quake.net/~xdcrlab/hp.html
Ultrasnd.Tchnlgy: http://www.quake.net/~xdcrlab/Ultrasound.html

From owner-ageing@net.bio.net Mon Sep 25 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!news-e1a.megaweb.com!newstf01.news.aol.com!newsbf02.news.aol.com!not-for-mail
From: lcuster@aol.com (Lcuster)
Newsgroups: bionet.molbio.ageing
Subject: Re: Oxidative stress as a cause for ageing
Date: 25 Sep 1995 20:03:46 -0400
Organization: America Online, Inc. (1-800-827-6364)
Lines: 29
Sender: root@newsbf02.news.aol.com
Message-ID: <447g12$r40@newsbf02.news.aol.com>
References: <Pine.SCO.3.91.950921134107.29268A-100000-100000-100000-100000@skull.cc.fc.ul.pt>
NNTP-Posting-Host: newsbf02.mail.aol.com
X-Newsreader: AOL Offline Reader

I just read about oxidative DNA damage in "DNA Repair and Mutagenesis" by
E. Friedberg, G. Walker, and W. Siede, 1995, ASM Press.  Below are a few
of the references cited in this book.

Damage to the DNA bases in mammalian chromatin by hydrogen peroxide in the
presence of ferric and cupric ions.  Arch. Biochem. Biophys. 285:317-324,
1991.

Toxic DNA damage by hydrogen peroxide through the Fenton rxn in vivo & in
vitro.  Science 240:1302-1309.

Sites & thermodynamic quantities assoc. w/proton & metal ion interaction
w/RNA, DNA, and their bases, nucleosides, and nucleotides. Chem Rev.
71:439-481.

Oxidative damage to DNA in mamm. chromatin  Mutat. Res 275:331-342.

DNA ox damage: Its mech. & measurement in mamm. systems FEBS Lett.
281:9-19


Hope this Helps

--------------------------------------------------------------------------
----
Laura Custer, Graduate Student
Chemistry Dept.
The American University
Lcuster@aol.com

From owner-ageing@net.bio.net Mon Sep 25 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!news-e1a.megaweb.com!newstf01.news.aol.com!uunet!in2.uu.net!news.compuserve.com!news.production.compuserve.com!news
From: George M. <75763.12@CompuServe.COM>
Newsgroups: bionet.molbio.ageing
Subject: Telomeres to the rescue?
Date: 26 Sep 1995 02:46:27 GMT
Organization: New York University
Lines: 10
Message-ID: <447pi3$qpd$2@mhadf.production.compuserve.com>

What role do telomeres play in cell cycle regulation?  

Does telomere length determine the point at which cell death
occurs?  If so, is there one chromosome who acts as the "watchdog"
for the cell to trigger death?

Thank you in advance for your insights.

-- 
George M. 

From owner-ageing@net.bio.net Mon Sep 25 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!news.sprintlink.net!simtel!harbinger.cc.monash.edu.au!yarrina.connect.com.au!news.mel.aone.net.au!OzEmail!usenet
From: Peter Hynes <pjhynes@ozemail.com.au>
Newsgroups: bionet.molbio.ageing
Subject: Re: What evidence for non-ageing species?
Date: 22 Sep 1995 22:16:02 GMT
Organization: OzEmail Pty Ltd - Australia
Lines: 51
Message-ID: <43vcj2$c40@oznet03.ozemail.com.au>
NNTP-Posting-Host: slmel3p54.ozemail.com.au

On Mar 16, 1995 steve@chambers.ak.planet.co.nz (Steve Chambers) wrote :
>In an article in Scientific American on the very old, it reported 
>that after 80 there was no relationship between old age and high
>death rates in humans.

As I recall this topic has reared its head several times. I have two
queries which appear to be loosely related to Steve's - and others'-
interests.

1/ The alleged independence of death rates from chronological age
   in the very old.

*** Is this not merely an artefact of the Gaussian Curve ?

When t>2*sigma, dN/dt --> 0 as a bit of algebra or simple inspection
of the curve will show.
So long as a group of individuals is far from its specie's mean age
of death, the death RATE looks approx constant.
In human males the mean age appears to be around 70.7 yr with an
SD of about 8.5 yr. (The death rate curve is approx normal.)
So IF you make it past say 85, your chances of dying APPEAR to
level out.
Comments?

2/ An oft used index of death rates is the "Age Specific Mortality,
   Qx".
   See : Carey et al, "Slowing of Mortality Rates at Older Ages in
                       Large  Medfly Cohorts"
         Science Vol 458, 457-461, 16\10\92
    and  Curtsinger et al, "Demography of Genotypes : Failure of
         the Limited Lifespan Paradigm in D. melanogaster",
            Science 258, 461-464, 16\10\92

 These guys have real good data - over 10^6 flies fed and pampered
till they all kicked off from old age. Trouble is, even if you 
start with a million, at the end you have just a handful left.
And that leads to LARGE fluctuations in the stats for the tail
enders. (Small sample noise.)
Bad for Qx which is supposed - in the above papers - to show
departures from the Gompertz Law in a large, ageing population.

***
So, who thinks these papers really do show that? who has read'em,
anyway? If Qx does not validate non-Gompertzian trends, where
does that leave the assertion of a slowdown in death rates
among the really old?
Or am I missing it altogether?
Comments?
***

Bye all ... PJH.

From owner-ageing@net.bio.net Mon Sep 25 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!news.nic.surfnet.nl!highway.LeidenUniv.nl!rulc18
From: d_quale@dds.nl (Angelo Schouten)
Newsgroups: bionet.molbio.ageing
Subject: Re: Oxidative stress as a cause for ageing
Date: Tue, 26 Sep 95 18:04:24 GMT
Organization: U-Leiden
Lines: 27
Message-ID: <449fkh$88m@highway.LeidenUniv.nl>
References: <Pine.SCO.3.91.950921134107.29268A-100000-100000-100000-100000@skull.cc.fc.ul.pt>
NNTP-Posting-Host: rulc18.leidenuniv.nl
X-Newsreader: News Xpress Version 1.0 Beta #3

In article <Pine.SCO.3.91.950921134107.29268A-100000-100000-100000-100000@skull.cc.fc.ul.pt>,
   Jorge Braz <qjpcbraz@cc.fc.ul.pt> wrote:
>	I am looking for any information about the reactions of oxygen 
>radicals (o2.-, HO., O1, H2O2) with the DNA bases especially the rate 
>constants and the products percentages of this reactions.
>			 Jorge Braz

This is a job for a physical chemist, Jorge. Perhaps theoretical calulations 
have been done. It is of no use to look for rate constant(s) of hydroxyl radicals
with DNA bases in certain media. (.OH) is so extremely reactive and anti-specific/selective 
that it virtually does not excist. It even reacts with inert gases like Xenon.
Therefor the toxicity of H2O2 in Fenton RedOx coupled reactions is related to 
the ease at which .OH (or superoxide, depending on the reaction conditions)
is "released". That is the rate determining step. 
H2O2 should have little genotoxicity "an sich" -as a pure substance.

You could consider to do time resolved pulsed EPR (Spin ECHO experiments).  
All of the intermediates .OH and (O2)- and singlet/triplet O
have unpaired electron spins. Inducing the radical species (photolytic: UV) and watch the 
EPR signals become silent/silenced. Calibrate with a known spin marker like DPPH or TEMPO(L).
Continuous Wave EPR is probably to slow to detect/determine .OH species.
The solvent is important as well. Excited dioxygen species like singlet oxygen live longer in 
apolar and aprotic media than i.g. in water. You only need 10E-12 spins to get an EPR signal.

Best regards,

Angelo Schouten

From owner-ageing@net.bio.net Tue Sep 26 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!swrinde!emory!metro.atlanta.com!news.sprintlink.net!sjuvm!lockshin
Nntp-Posting-Host: 149.68.2.20
Date: Tue, 26 Sep 1995 13:50:07 -0400
From: "LOCKSHIN, RICHARD A" <LOCKSHIN@sjumusic.stjohns.edu>
Newsgroups: bionet.cellbiol,bionet.celegans,bionet.drosophila,bionet.general,bionet.molbio.ageing,bionet.neuroscience
Subject: <none>
Message-ID: <26SEP95.14939704.0124@sjumusic.stjohns.edu>
Sender: usenet@sjumusic.stjohns.edu
Organization: St. John's University
Lines: 31
Xref: biosci bionet.cellbiol:3023 bionet.celegans:592 bionet.drosophila:1417 bionet.general:17311 bionet.molbio.ageing:1994 bionet.neuroscience:10450

NYC AREA CELL DEATH CLUB MEETING
WED. OCT. 11, 1995, 6:30 PM
Rockefeller University, 1230 York Ave.
Tower Building Room 301
6:30-7 Pizza, 7-8:30 Talks and discussion
Free parking after 5PM at 66th St. & York Ave.
Speakers:
1.  Jonathan Tilly, Harvard
	Molecular Basis of Ovarian Cell Death
2.  Marcel Verheij, Memorial Sloan Kettering
	Environmental stresses signal apoptosis
	through a ceramide-initiated SAPK/JNK-
	mediated cascade.

To help plan for pizza, talk, parking, etc, if
you have not previously attended, please call Dr.
Zakeri's LAB at 718:  997-3429 to let them know
of the number of people expected and if parking
is needed.

Organizer:

Zahra Zakeri, Queens College, Fax 718:  997-3445
Phone 718:  997-3417

Raymond Birge
Rockefeller University, Fax 212:  327-7943
Phone 212:  327-7412

email pro-temp:  lockshin@sjumusic.stjohns.edu


From owner-ageing@net.bio.net Tue Sep 26 23:00:00 1995
Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!news.compuserve.com!news.production.compuserve.com!news
From: JULIO KARWOSKI <102225.2745@CompuServe.COM>
Newsgroups: bionet.molbio.ageing
Subject: Re: Telomeres to the rescue?
Date: 27 Sep 1995 06:31:13 GMT
Organization: CompuServe, Inc. (1-800-689-0736)
Lines: 19
Message-ID: <44ar3h$klp$1@mhadf.production.compuserve.com>
References: <447pi3$qpd$2@mhadf.production.compuserve.com>

George: Responding to your inquiry about telomeres I should say 
that Allsop & Harley have found an average critical telomere 
length to be 0-2kbp at the onset of senescence. Also, at onset of 
senescense there are still many telomere sequences left on the 
average but since telomeres are heterochromatic, the prevailing 
theory is that the heterochromatin traps the first few genetic 
bases which will become silent. Yes, at this point senility is 
still reversible according to experimental evidence by J.W.Shay 
and W.E.West because actual genetic sequences have not been lost 
just yet. Your question about a senescent factor being expressed 
is partially right, actually there is some evidence of an anti 
senescent regulatory factor expressed by those first few genes 
but when they become engulfed in heterochromatin they become 
silent and senescence will occur. This is a hot area in biology 
and its interesting to know that some people like yourself are 
interested to learn more about whats making us old.
    best regards,
    
    Julio Karwoski

From owner-ageing@net.bio.net Wed Sep 27 23:00:00 1995
Path: biosci!agate!howland.reston.ans.net!vixen.cso.uiuc.edu!news.uoregon.edu!waikato!waikato.ac.nz!hawthorn
From: hawthorn@waikato.ac.nz
Newsgroups: bionet.molbio.ageing
Subject: Re: Telomeres to the rescue?
Message-ID: <1995Sep28.170323.40864@waikato.ac.nz>
Date: 28 Sep 95 17:03:23 +1200
References: <447pi3$qpd$2@mhadf.production.compuserve.com> <44ar3h$klp$1@mhadf.production.compuserve.com>
Organization: University of Waikato, Hamilton, New Zealand
Lines: 24

In article <44ar3h$klp$1@mhadf.production.compuserve.com>, JULIO KARWOSKI <102225.2745@CompuServe.COM> writes:
> George: Responding to your inquiry about telomeres I should say 
> that Allsop & Harley have found an average critical telomere 
> length to be 0-2kbp at the onset of senescence. Also, at onset of 
> senescense there are still many telomere sequences left on the 
> average but since telomeres are heterochromatic, the prevailing 
> theory is that the heterochromatin traps the first few genetic 
> bases which will become silent. Yes, at this point senility is 
> still reversible according to experimental evidence by J.W.Shay 
> and W.E.West because actual genetic sequences have not been lost 
> just yet. Your question about a senescent factor being expressed 
> is partially right, actually there is some evidence of an anti 
> senescent regulatory factor expressed by those first few genes 
> but when they become engulfed in heterochromatin they become 
> silent and senescence will occur. This is a hot area in biology 
> and its interesting to know that some people like yourself are 
> interested to learn more about whats making us old.
>     best regards,
>     
>     Julio Karwoski

... so you inject your rat with telomerase. What happens? Dead rat?

Ian H

From owner-ageing@net.bio.net Sat Sep 30 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!news.sprintlink.net!in2.uu.net!ayrton.eideti.com!usenet
From: bob chapel <bchapel@eideti.com>
Newsgroups: bionet.molbio.ageing
Subject: Re: RE: THINNING HAIR?....MINOXIDIL USERS?...
Date: 1 Oct 1995 06:46:09 GMT
Organization: Clinical Aesthetic Nursing Associates
Lines: 5
Message-ID: <44ldfh$rs5@ayrton.eideti.com>
References: <441mjo$3ht@artemis.it.luc.edu>
NNTP-Posting-Host: annex1-8.infi-net.com
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.1N (Windows; I; 16bit)
To: yrutman@orion.it.luc.edu

I've been using pentadecanoic acid for some time and feel it is of some 
value but I've been unable to find literature supporting it's actions.  
If you could direct me to some LEGITIMATE experimental data I'd be both 
grateful AND likely to change suppliers.....thanks


From owner-ageing@net.bio.net Sat Sep 30 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!news.sprintlink.net!in2.uu.net!ayrton.eideti.com!usenet
From: bob chapel <bchapel@eideti.com>
Newsgroups: bionet.molbio.ageing
Subject: Re: DHEA
Date: 1 Oct 1995 07:03:00 GMT
Organization: Clinical Aesthetic Nursing Associates
Lines: 13
Message-ID: <44lef4$rs5@ayrton.eideti.com>
References: <drierac.67.00129315@deakin.edu.au>
NNTP-Posting-Host: annex1-8.infi-net.com
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.1N (Windows; I; 16bit)
To: drierac@deakin.edu.au

Chris-You might want to take a look at the book by Ward Dean and John 
Morgenthaler "Smart Drugs and Nutrients" it contains a chapter on DHEA 
and discusses it's many demonstrated and anecdotal uses(weight loss, 
attenuation of alzheimers,anti-tumor,anti-aging,anti-cancer effects.  It 
has received positive evaluations in reputable medical journals (eg 
Lancet 1989,2(8670)pp.1048-9 "Dehydroepiandrosterone and alzheimers 
disease"  )  It's use in humans is considered very experimental and ,not 
surprisingly,it is rather controversial. Those who do use it are very 
strongly advised to get regular assays and to d/c it's use when their 
blood levels return to that of a normal 20yo.  Hope this helps. If you 
find anything of interest do return the favor as I too am interested.
Bob Chapel,MSW,RN (USA)


From owner-ageing@net.bio.net Sat Sep 30 23:00:00 1995
Path: biosci!bcm.tmc.edu!cs.utexas.edu!news.sprintlink.net!in2.uu.net!ayrton.eideti.com!usenet
From: bob chapel <bchapel@eideti.com>
Newsgroups: bionet.molbio.ageing
Subject: Re: DHEA
Date: 1 Oct 1995 07:03:13 GMT
Organization: Clinical Aesthetic Nursing Associates
Lines: 13
Message-ID: <44lefh$rvs@ayrton.eideti.com>
References: <drierac.67.00129315@deakin.edu.au>
NNTP-Posting-Host: annex1-8.infi-net.com
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.1N (Windows; I; 16bit)
To: drierac@deakin.edu.au

Chris-You might want to take a look at the book by Ward Dean and John 
Morgenthaler "Smart Drugs and Nutrients" it contains a chapter on DHEA 
and discusses it's many demonstrated and anecdotal uses(weight loss, 
attenuation of alzheimers,anti-tumor,anti-aging,anti-cancer effects.  It 
has received positive evaluations in reputable medical journals (eg 
Lancet 1989,2(8670)pp.1048-9 "Dehydroepiandrosterone and alzheimers 
disease"  )  It's use in humans is considered very experimental and ,not 
surprisingly,it is rather controversial. Those who do use it are very 
strongly advised to get regular assays and to d/c it's use when their 
blood levels return to that of a normal 20yo.  Hope this helps. If you 
find anything of interest do return the favor as I too am interested.
Bob Chapel,MSW,RN (USA)


From owner-ageing@net.bio.net Sat Sep 30 23:00:00 1995
Path: biosci!agate!library.ucla.edu!info.ucla.edu!news.ucdavis.edu!rocky!fzcboe
From: fzcboe@rocky.ucdavis.edu (Carl Boe)
Newsgroups: bionet.molbio.ageing
Subject: Re: What evidence for non-ageing species?
Date: 1 Oct 1995 22:36:50 GMT
Organization: University of California, Davis
Lines: 105
Message-ID: <44n562$17l@mark.ucdavis.edu>
References: <43vcj2$c40@oznet03.ozemail.com.au>
NNTP-Posting-Host: rocky.ucdavis.edu
X-Newsreader: TIN [version 1.2 PL2]

Peter Hynes (pjhynes@ozemail.com.au) wrote:
: On Mar 16, 1995 steve@chambers.ak.planet.co.nz (Steve Chambers) wrote :
: >In an article in Scientific American on the very old, it reported 
: >that after 80 there was no relationship between old age and high
: >death rates in humans.

: As I recall this topic has reared its head several times. I have two
: queries which appear to be loosely related to Steve's - and others'-
: interests.

: 1/ The alleged independence of death rates from chronological age
:    in the very old.

: *** Is this not merely an artefact of the Gaussian Curve ?

: When t>2*sigma, dN/dt --> 0 as a bit of algebra or simple inspection
: of the curve will show.
: So long as a group of individuals is far from its specie's mean age
: of death, the death RATE looks approx constant.
: In human males the mean age appears to be around 70.7 yr with an
: SD of about 8.5 yr. (The death rate curve is approx normal.)
: So IF you make it past say 85, your chances of dying APPEAR to
: level out.
: Comments?

Of course, this is a statement about declining numbers at risk with age. 
In older ages, N is quite small and so the rate of change in absolute
terms (i.e. the number of deaths occuring per unit time) is also small. 
The death rate, as usually defined, conditions on the average 
number of individuals exposed to mortality risk in the interval (cf. Qx 
below).  Statements about mortality leveling off and non-Gompertz 
mortality at old age is a statement about the normalized tail behavior 
(i.e. dN/dt / N --> ??? ).

: 2/ An oft used index of death rates is the "Age Specific Mortality,
:    Qx".
:    See : Carey et al, "Slowing of Mortality Rates at Older Ages in
:                        Large  Medfly Cohorts"
:          Science Vol 458, 457-461, 16\10\92
:     and  Curtsinger et al, "Demography of Genotypes : Failure of
:          the Limited Lifespan Paradigm in D. melanogaster",
:             Science 258, 461-464, 16\10\92

:  These guys have real good data - over 10^6 flies fed and pampered
: till they all kicked off from old age. Trouble is, even if you 
: start with a million, at the end you have just a handful left.
: And that leads to LARGE fluctuations in the stats for the tail
: enders. (Small sample noise.)
There is always increasingly large fluctuations in the tails.  The point 
of the million is that you can go much further into the tail region 
before demographic stochasticity becomes a problem.  

 : Bad for Qx which is supposed - in the above papers - to show
: departures from the Gompertz Law in a large, ageing population.

For any fixed x, the s.e. of the estimated Qx will be smaller, the larger
the number of flies alive at x.  So to get lots alive at x, you start 
with huge numbers.  Of course there will always be an age old enough so 
that you don't have very many left alive and, at that age, the estimates 
wil be quite uncertain.

: ***
: So, who thinks these papers really do show that? who has read'em,
: anyway? If Qx does not validate non-Gompertzian trends, where
: does that leave the assertion of a slowdown in death rates
: among the really old?
Well, I think the phenomenon cannot be denied, although the *reasons* for 
the decline as well as the extent of the levelling off in other species 
remain important issues for current research.  Alternative explanations 
include cage and density effects, genetic heterogeneity of individuals.  
These effects could produce a leveling off in the following way.  If 
mortality increases with density, then as time progresses, the density 
within a cage falls, as more and more flies die off.  This leaves the 
oldest flies with very low density and therefore with much lower 
mortality levels.  The argument for genetic heterogeneity is that the 
initial population consists of a mixture of genetically different 
individuals and genetic endowments strongly influence mortality rates.  
Thus flies with high mortality genes die off early, leaving a greater and 
greater proportion of flies with low mortality genes.  Selection proceeds 
thorugh the ages so that only the most robust of flies live to old age.  
If the selection process is fast enough, mortality rates can decline in 
the aggregate (even when they are remaining constant or even increasing 
for all individuals).

I think to a large extent these were addressed in the original articles 
and responses to letters that appeared later in Science.
The Carey et al. article conducted three separate experiments, two of 
which did not involve flies caged in groups but rather in isolation.  
There is still "confinement" in these isolation experiments, but there is 
fixed density.  The qualitative findings were the same as for the 1 
million  experiment that used grouped cages:  the mortality 
slowdown persists across all three experiments.   The experiments in 
Curtsinger et al. controlled  for genetic variation by using pure strains 
of Drosophila.  While genetics played a considerable role in determining 
longevity, within each strain the same mortality levelling off was 
observed.  

: Bye all ... PJH.

--Carl Boe
UC Davis


p.s. disclaimer:  I have a vested interest in the above as I am Jim 
Carey's lab at Davis.

